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Blastocystis is one the most common eukaryotic organisms found in the human 
gut. Several reports have identified its role in gastrointestinal disorders, 
although its pathogenicity still needs to be elucidated. The study explores the 
roles of antimicrobial peptides expressed in the colon when Blastocystis infect 
humans. Antimicrobial peptides (AMPs) are elements of the innate immunity 
and contribute in the protection of the intestinal mucosa from microbial 
invasion. These AMPs are cationic which makes them bind to negatively-
charged membrane surfaces. AMPs then disrupt the membrane and may cause 
cytoplasmic leakage and kill the cell.  Aside from this direct killing, AMPs have 
also been reported to modulate downstream host immune responses. This study 
therefore investigates human colonic AMPs in the context of host-pathogen 
interactions occurring between the human host and Blastocystis. A modified 
drug screening assay was used to identify the susceptibility of Blastocystis to 
three colonic AMPs (cathelicidin, human beta-defensin 1 and human beta-
defensin 2). LL-37, a fragment of cathelicidin antimicrobial peptide (CAMP), 
was found to have broad activity on various Blastocystis isolates in terms of 
growth inhibition. Its membrane disruptive effect on representative isolates was 
also revealed using conventional and imaging flow imaging cytometry as well 
as electron microscopy. However, Blastocystis subtype (ST) 7 isolates showed 
relative resistance against the peptide. This is due to the ST’s ability to secrete 
proteases that can degrade LL-37 and alter the surrounding pH that in turn 
attenuate the peptide’s activity. The thicker surface coat of ST7 isolates may 
also confer resistance against LL-37 killing. Co-culture experiments between 
intestinal epithelial cells and Blastocystis revealed that the parasite can induce 
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LL-37 gene expression both in HT-29 cells and in mouse intestinal explants. 
LL-37 was also found to be secreted in the cell culture supernatant when the co-
cultured with Blastocystis. Results in this study suggest a significant role for 
AMPs, particularly LL-37, in human Blastocystis infections. The data could 
also be relevant in clarifying how the parasite achieves colonization and other 
pathogenic events in the human gut. Lastly, this study points toward the many 
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1.1 Historical background 
 
The name ‘Blastocystis’ first appeared in scientific literature at the beginning of 
the 20th century. Although several investigators described an organism they 
believed to be the parasite in the middle of the 1800’s, it was only in 1911 when 
the requirements for nomenclature of Blastocystis was fulfilled. In the following 
year, Brumpt gave the name ‘Blastocystis hominis' to the organisms he found in 
humans. This name then became widely used to refer to a gut eukaryote which 
has a round shape and semi-hollow appearance (Clark et al., 2013; Zierdt, 1973, 
1991). Throughout the 20th century, more isolates have been found, not just in 
humans but also in animals and insects. There were controversies regarding its 
status and some investigators argued that Blastocystis were just degenerate or 
cysts forms of other known intestinal protozoans. There was also a suggestion 
that it was a yeast. Cultural and morphological characteristics however showed 
that it was suitable to classify it under protozoa (Zierdt, 1991). Nucleic acid-
based approaches have definitively separated Blastocystis from yeasts. 
Analyses of partial and full SSU rRNA gene sequences of various isolates 
showed that Blastocystis do not form a cluster with fungi (Tan et al., 2002). 
 
1.2 Classification of Blastocystis 
 
Establishing Blastocystis’ taxonomic status was not straightforward. It was 
partly due to the lack of unique and apparent characteristics that could 
distinguish it from other unicellular eukaryotes, and therefore also rooted in the 
complexity of the protistan group itself. The classification of unicellular 
3 
 
eukaryotes underwent several revisions (Adl et al., 2012; Cavalier-Smith, 1993, 
1998; Levine et al., 1980). A 1998 classification placed Blastocystis under 
Kingdom Chromista, Subkingdom Chromobiota, Infrakingdom, Heterokonta, 
Subphylum Opalinata and Class Blastocystea (Cavalier-Smith, 1998; Tan et al., 
2002). Blastocystis, therefore, does not belong to protozoa but to another 
Kingdom (Chromista). It is thus more accurate to refer to Blastocystis as a 
protist rather than a protozoan. Small sub-unit ribosomal RNA (SSU rRNA) 
gene sequence analysis clustered Blastocystis spp. along with the group 
Stramenopiles. The most recent grouping placed the group Blastocystis at the 
same level with Opalinata under Stramenopiles, which belongs to the clade Sar 
(Adl et al., 2012). The organism however exhibits characteristics which are 
unusual to the other members of the group. For example, Blastocystis lacks cilia, 
possesses no plastids and therefore not photosynthetic (Clark et al., 2013; 
Silberman et al., 1996; Tan, 2008). Blastocystis isolates are highly polymorphic 
both in morphology and genetics (Clark, 1997; Yoshikawa et al., 2016). 
Previously, the naming of isolates was based on host origin, morphological 
features and in vitro culture characteristics and/or electrophoretic karyotypes 
(Yoshikawa et al., 2016). The problem that arose with this approach was that 
there were genetically dissimilar isolates isolated in one type of host (e.g. 
humans); and also, an isolate could be found in many different types of hosts. 
In short, the lack of apparent host specificity renders the approach of naming an 
isolate based on host origin and other factors untenable. A consensus was made 
in 2007 and classified human Blastocystis isolates into 9 subtypes (STs) based 
on complete SSU rRNA gene sequences (Stensvold et al., 2007). The term 
‘Blastocystis hominis’ was dropped as a collective name for these isolates 
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because reptilian and amphibian isolates may also fall into these STs. These 
isolates were then classified simply as Blastocytis spp. At present, seventeen 
different Blastocystis STs mainly from mammalian and avian hosts have been 
proposed. Isolates from humans are designated as STs 1-9 (Yoshikawa et al., 
2016). Subtypes of Blastocystis can be determined by genetic analyses, but STs 
also exhibit differences in size, morphology, growth in culture, host range, drug 
resistance, host immune response, adhesion to host cells and protease activities 
(Mirza et al., 2011a; Roberts et al., 2014a; Tan, 2008; Teo et al., 2014; Wu et 
al., 2014). Studies have also indicated that ST identity may determine 
symptomatology and pathogenic potential (Casero et al., 2015; Roberts et al., 
2014b) although other studies did not find a strong basis for this (Nagel et al., 
2012; Souppart et al., 2010).  
 
1.3 Biology and life cycle of Blastocystis 
 
A typical Blastocystis cell has a spherical shape. Under the microscope, 
Blastocystis appear round with a prominent central vacuole. In the vacuolar 
form of the parasite, the cytoplasm is usually located at the edge where the 
nucleus (or several nuclei) and other organelles can be found. Granular forms 
can also be observed and some multi-vacuolar forms have been reported (Tan, 
2008; Zhang et al., 2012, 2012). Irregularly-shaped cells are also seen and these 
have been labelled as amoeboid forms in some studies (Rajamanikam and 
Govind, 2013; Tan, 2008; Zhang et al., 2012). Investigators have also identified 
multinucleated and avacuolar forms but the vacuolar forms constitute much of 
cells found in any type of samples. Cultivation of the parasite requires anaerobic 
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conditions. The proposed life cycle of the organism commences when the 
environmentally-resistant cyst forms are ingested through contaminated food 
and water. There is excystment when Blastocystis reaches the intestines which 
by then develops into vegetative forms. The parasite then undergoes 
colonization in the large intestines. Some of the forms may develop into cysts 
which are passed on the feces. Blastocystis in fecal specimens and in cultures 
assumes different forms. Blastocystis reproduces by binary fission although 
some researchers proposed alternative reproductive modes for the parasite 
(Clark et al., 2013; Jeremiah and Parija, 2013; Tan, 2004, 2008). Images of 
plasmotomy or budding have been supposedly demonstrated (Yamada and 
Yoshikawa, 2012) but these could just have been asymmetrical binary fission 
(Tan and Stenzel, 2003).  Under light microscopy, various forms have been 
described and interpreted as representing alternative modes of reproduction. 
However, these have not been supported by other methods (Tan, 2004; Yamada 
and Yoshikawa, 2012). Schizogony has also been put forward as a mode of 
reproduction in Blastocystis (Govind et al., 2002). This involves multiple fission 
that results in the production of more cells in one event compared to binary 
fission. This developmental event has been suggested to occur in Blastocystis 
as an attempt to explain the proliferative nature of the parasite in-vivo and in-
vitro (Govind et al., 2002). Solid evidence for these alternative modes have not 
been achieved as yet. And at present, binary fission is the only mode of 
reproduction in Blastocystis with clear and established proofs (Tan, 2008; 
Yamada and Yoshikawa, 2012). The conventional method for detection of 
Blastocystis is by microscopic observation in clinical (mainly fecal specimens) 
and environmental samples. This method, however, is not adequate to 
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1.4 Clinical relevance of human Blastocystis infections 
 
Blastocystis is considered an important water-borne pathogen (World Health 
Organization, 2008). It has been implicated in waterborne disease outbreaks 
(Anuar et al., 2013; Baldursson and Karanis, 2011). Infection with Blastocystis 
is usually asymptomatic but when symptoms are observed, they are usually self-
limiting. The symptoms usually associated with Blastocystis include abdominal 
pain, diarrhea and flatulence. There were also surveys that indicated urticaria as 
a symptom. There were controversies regarding the pathogenic status of 
Blastocystis. Several reports indicated that it is an opportunistic parasite and that 
the symptoms linked with it are a result of bystander effects (Alemu et al., 2011; 
Chandramathi et al., 2012; Teo et al., 2014). Blastocystis has been associated 
with a number disease states such as irritable bowel syndrome (IBS), chronic 
diarrhea especially in children and colitis in numerous studies (Coyle et al., 
2012; Kiani et al., 2016; Maçin et al., 2016; Poirier et al., 2012; Roberts et al., 
2014b; Tan, 2008). In line with this, cell culture experiments showed that 
Blastocystis can adhere to epithelial cells and that it is capable of compromising 
epithelial barrier integrity. Animal studies have also reported the ability of the 
parasite to colonize the intestines, upregulate inflammatory cytokines and 




1.5 Distribution of Blastocystis spp. 
 
Blastocystis is the most common eukaryote isolated in humans. More than 1 
billion people in the world are estimated to harbor the parasite. Infection rates 
vary from 0.5 to 62% in surveys conducted at different locations all over the 
world (Clark et al., 2013; Scanlan et al., 2014). These surveys, however, were 
not uniform in terms of methods of detection, and sampling factors related to 
social, environmental and economic backgrounds. In some of these studies, 
particular STs were not identified. A recent survey in Senegal has stretched the 
range of infection rates further. In a study among children living beside a river 
basin, Blastocystis infection was at 100% prevalence. (El Safadi et al., 2014). 
In general, there is higher prevalence in developing countries compared to 
developed ones (Beyhan et al., 2015; Clark et al., 2013; Nithyamathi et al., 
2016; Ramírez et al., 2016).  
 
Blastocystis ST1-9 are  human isolates and, with the exception of ST9, can be 
found in other animal hosts as well. Surveys indicated that Blastocystis ST1 and 
ST3 were the most common isolated subtypes worldwide (Clark et al., 2013). 
The geographical distribution of subtypes however varied from one continent 
to another. Blastocystis ST4, for example, was detected also frequently in 
Europe (Alfellani et al., 2013). Blastocystis ST4, 6, 7 and 9 were common 
among Japanese patients (Yoshikawa and Iwamasa, 2016). In South American 
countries, ST4 was almost non-existent and ST2 registered high prevalence 




1.6 Antimicrobial peptides 
 
Antimicrobial peptides (AMPs) are small molecules which may comprise 6 to 
100 amino acids in length (Peters et al., 2010). AMPs are considered primitive 
molecules which evolved 2.6 billion years ago (Gordon et al., 2005). AMPs are 
found in many types of organisms from prokaryotic to eukaryotic, from 
unicellular (e.g. bacteriocins in bacteria) to multicellular organisms, from plants 
to insects, animals and humans (Li et al., 2012; Peters et al., 2010). More than 
2,000 AMPs have been identified from various sources, and still more are being 
discovered (Li et al., 2012; Wang et al., 2015). In animals, AMPs can be found 
in different types of tissues. There are AMPs secreted by circulating leukocytes 
as well as epithelial cells lining the skin and the gut. There are also others 
produced by specialized cells such as Paneth cells in the intestines (Andreu and 
Rivas, 1998; Lehrer and Ganz, 1999). 
 
For plants and animals, AMPs are important elements in the innate immunity 
against pathogenic microorganisms (Lehrer and Lu, 2012).  Almost every AMP 
is composed of a hydrophilic, hydrophobic and cationic amino acids arranged 
in a molecule that can assume an amphipathic structure (Zasloff, 2002). The net 
positive charge is due to the presence of a higher content in arginine and lysine 
amino acids than in aspartic acid and glutamic acid. This property is further 
reinforced by a C-terminal amidation (Chow et al., 2013). Having cationic 
groups, AMPs can strongly bind to the surfaces of bacteria (which has more 
negative charges) while having weak affinity towards cell membranes of 
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multicellular organisms (Zasloff, 2002). All AMPs originate from larger 
molecules with a corresponding signal sequence (Zasloff, 2002).  
 
AMP-mediated cell killing includes the following steps: Attraction of AMP to 
membrane surface by electrostatic bonding; then, attachment to the cell 
membrane by traversing several structures. In the case of bacteria, these 
structures may include capsular polysaccharides, teichoic and lipoteichoic 
acids. Last step would be peptide insertion with subsequent membrane 
permeability (Brogden, 2005). There are several hypotheses on how AMPs 
actually kill microbes. The main theory is that the killing of microbes is due to 
the molecule’s ability to cause pores to form on the membrane. Another 
supposition is that AMPs may cause depolarization of the bacterial membrane 
or they can cause unequal distribution of lipids which lead to abnormal 
membrane functions. AMPs can also bind to internal and critical targets or that 
it can induce hydrolases that degrade the cell wall (Gordon et al., 2005; Zasloff, 
2002). Many AMPs are known to have a fast killing effect on some microbial 
cells (Yu et al., 2016). LL-37 has been shown to saturate the outer membrane 
of Escherichia coli cells within one minute and permeabilize the cytoplasmic 
membrane within 16 min (Sochacki et al., 2011).  Another AMP, Cecropin A, 
disrupts the bacterium’s membrane within 2 min (Rangarajan et al., 2013). 
Aside from direct killing effect of microbial cells by various mechanisms, 
several AMPs could also have other functions (Wang, 2014). AMPs can serve 
as mediators for recruitment of other immune cells. They can also function as 
modulators for immune response by binding to antigens. In general, acquired 
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resistance against AMPs seems to be a rare phenomenon (Fjell et al., 2012; 
Wang et al., 2015). 
 
1.7 AMPs of the human gut 
 
AMPs are present in all human tissue which is normally exposed to 
microorganisms such as the skin and the mucosae (Wiesner and Vilcinskas, 
2010). Aside from the physical barrier, AMPs secreted into the intestines also 
provide protection from pathogens (Table 1.1). Paneth cells, which are found in 
the small intestines, are main sources of AMPs. These cells however are fewer 
in the large intestines where most AMPs are produced by epithelial cells (Bevins 
and Salzman, 2011; Elphick and Mahida, 2005). Defensins and cathelicidins are 
among the major groups of AMPs found in the lower portion of the 
gastrointestinal tract (Bevins and Salzman, 2011). AMPs are significant factors 
in maintaining homeostasis in the gut along with the commensal and mutualistic 
microbiota (Muniz and Yeretssian, 2012; Ostaff et al., 2013). And along with 
mucins which line the intestinal tract, these three elements constitute the front 
line of host defense against invasion of harmful microorganisms (Moal and 
Servin, 2006). 
 
Defensins serve as endogenous antibiotics with microbicidal activity against 
Gram-negative and Gram-positive bacteria, fungi, viruses, and protozoa. 
Defensins’ molecular masses are low, usually at 3-6 kDa. They are 30–40 amino 
acids in length. All human defensins share a triple-stranded β-sheet core 
structure stabilized by three intramolecular disulfide bonds. Depending on the 
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position of these cysteine residues, defensins can be grouped into two major 
subfamilies: the α-defensins and the β-defensins. The cyclic peptide called θ-
defensin has not been isolated so far among humans. In human α-defensins, 
cysteine pairing pattern is 1:6, 2:4, 3:5. The total of six α-defensins includes 
human neutrophil peptides 1–4 (HNP1–4) produced by granulocytes and human 
defensin 5 and 6 (HD5 and HD6) produced by Paneth cells. The-α defensins 
(also referred to as cryptdins in mice) are most highly expressed in Paneth cells 
and neutrophils in humans, rats and other mammals, but not in mice. Human β-
defensins have 1:5, 2:4, 3:5 cysteine pairing pattern, although their three-
dimensional structures are similar to α-defensins. β-defensins (Fig. 1.1) are 
expressed by many types of epithelial cell, including colonocytes, and their 
expression in the intestinal epithelium is inducible, except for the expression of 
human β-defensin 1 (hBD-1). β-defensins have four subtypes, designated hBD-
1 to hBD-4. hBD-1 is ubiquitously expressed at all surfaces of the human body 
including the skin, the respiratory, urogenital and the gastrointestinal tract. 
hBD-2 and hBD-3 are inducible antimicrobial peptides expressed by 
enterocytes throughout the intestinal tract (Jäger et al., 2010). The six human α-
defensin peptides are encoded by only five defensin-α (DEFA) genes and the 
sequences of HNPs 1, 2, and 3 are almost identical (Bevins and Salzman, 2011; 












Fig. 1.1. Structures of human β-defensin 1 (A) and 2 (B) dimers. The β-sheets 
are in yellow while the flanking α-helix structures are in pink. Images obtained 
from Research Collaboratory for Structural Bioinformatics (RCSB) Protein 





Defensins are effective against numerous bacterial pathogens (Oppenheim et 
al., 2003). Aside from this direct effect, defensins also have other roles in 
immunity. For example, hBD-1 and hBD-2 (also known as DEFB4A) have 
chemo-attractant activity for cells expressing CC-chemokine receptor 6 
(CCR6), including dendritic cells. Some mouse intestinal α-defensins promote 
ion fluxes in epithelial cells. Human α-defensin 5 (HD5; also known as DEFA5) 
is a potent lectin and can neutralize bacterial exotoxins. Paneth cell defensins 
are stored as propeptides and require cleavage by trypsin, which is stored in 
Paneth cell granules as a zymogen as well. The exact mechanism by which 
defensins exert their bactericidal effect has still not been identified, but it has 
already become clear that they do not act with a uniform mechanism (Bevins 
and Salzman, 2011; Ganz, 2003; Jäger et al., 2013). 
 
Cathelicidins are characterized by a conserved N-terminal domain that is 
proteolytically cleaved to generate the mature, active peptide contained within 
the C-terminus (Wiesner and Vilcinskas, 2010). The only cathelicidin identified 
in humans is termed LL-37 indicating the 37-amino acid sequence (Fig. 1.2). 
The Cathelicidin Antimicrobial Peptide (CAMP) is expressed in various 
immune cells, in salivary glands, and in epithelia of respiratory, digestive and 
reproductive tracts while keratinocytes and intestinal cells can be induced to 
enhance expression. Its main effect is pore formation in bacterial membranes. It 
is also found to be capable of modulating toxic effects due to bacterial infection 
(Bucki et al., 2010).  LL-37’s other activities include chemotactic effect on 
blood cells, activation of histamin release from mast cells, or induction of 
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angiogenesis. Absence of LL-37 has been associated with chronic periodontal 











Fig. 1.2. Structure of LL-37 from RCSB PDB showing the slightly bent α-helix 





Table 1.1. Antimicrobial peptides in the gastrointestinal tract1 
Antimicrobial 
peptide 
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1.8 AMPs and Parasites 
 
There are numerous studies on the effect of AMPs on several bacterial species. 
Fewer, however, are the investigations on its action on eukaryotic organisms 
particularly on unicellular parasites. Two α-helical AMPs were found to have 
antimalarial activity. A hybrid AMP also had a lytic effect on Leishmania 
(Vizioli and Salzet, 2002). Mammalian AMPs such as myeloid AMPs, 
defensins, histatin and plasmin inhibited the growth of Leishmania while 
angiotensin and NK-2 AMPs were effective against Plasmodium. AMPs 
purified from amphibians were also microbicidal against a number of protozoan 
parasites including intestinal parasites such as Entamoeba histolytica, 
Cryptosporidium parvum and Blastocystis (Rivas et al., 2009; Torrent et al., 
2012). Regarding specific AMPs expressed in the human gut β-defensins 1 and 
2 were found to kill Cryptosporidium (Zaalouk et al., 2004). Peptides belonging 
to cathelicidin were also found to be broadly cytotoxic to Cryptosporidium 
sporozoites (but not to oocysts) (Huang et al., 1990). Other cationic peptides 
such as indolicin, phospholipase and lactoferricin could also decrease their 
viability (Carryn et al., 2011). In another intestinal parasite, Entamoeba, LL-37 
was not effective to kill it partly due to the organism’s secretion of cysteine 
proteases (Cobo et al., 2012). However, other derivatives of LL-37 can kill the 
parasite (Rico-Mata et al., 2013). 
 
For Blastocystis, no other studies could be found investigating the effect of 
AMPs on this ubiquitous eukaryote except a report on magainin. Magainin is an 
AMP secreted on the frog skin. Four analogs of this peptide were synthesized 
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and tested on several protistan parasites including Blastocystis. These peptides 
could kill the parasite to varying degrees depending on the α-helical content of 
the peptides (Huang et al., 1990).   
 
1.9 Study Objectives 
 
The barriers that may prevent or at least limit Blastocystis virulence include 
elements in both innate and adaptive immunity. Elements of innate immunity 
that are effective against most microorganisms may also be effective against 
Blastocystis. There are however limited studies exploring this aspect (i.e. 
immune responses) of host-pathogen interactions in the framework of human 
Blastocystis infections. The study’s intent was to contribute to exploring the 
significance of host AMPs when Blastocystis infects humans. This goal falls 
within the broader context of elucidating host immune responses against 
Blastocystis. 
 
This study in particular aimed to identify the effect of endogenous AMPs (e.g. 
defensins and cathelicidin) secreted by epithelial cells on various Blastocystis 
isolates (Fig. 1.3). The experiments also delved deeper into the lytic effects of 
one AMP which was found to affect all Blastocystis STs. Parallel to this, an 
alternative method for observing the effects of membrane-disrupting AMP on 
Blastocystis was sought. The result was the application of an imaging flow 
cytometry technique that focuses on Blastocystis shape as a determinant of 
viability of the parasite while also evaluating its various morphological forms. 
The resistance factors which cause variations in susceptibility among isolates 
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were also identified. Lastly, the ability of the parasite to modulate AMP 
expression and secretion in intestinal epithelial cells were also determined.  
 
This study also contributed to exploring the potential applications of AMPs. 
AMPs could be used as novel therapies or provide templates for future drugs 
(Peters et al., 2010). This study therefore identified the therapeutic potential of 
a few AMPs which could also be extended to other parasitic diseases. The 
variation in susceptibilities to AMPs of various isolates of Blastocystis provided 
additional basis for speciation of Blastocystis STs. When definitive 
classification of the parasite down to species level is pursued, host immune 
responses in Blastocystis infections could be understood more clearly in the 










Fig. 1.3. Framework of the study exploring the roles of endogenous colonic 
AMPs in Blastocystis infections. The questions marks indicate the particular 
aspects of this study: susceptibility of Blastocystis to AMPs, resistance factors 


















Blastocystis is known to colonize the large intestines. When this happens, the 
host mounts a series of immune responses. Past in-vitro and in-vivo experiments 
indicated that the parasite can induce expression of GM-CSF and IL-8 in 
intestinal epithelial cells. Blastocystis secreted proteases can also stimulate 
other cytokines IL-1 β, IL-6 and TNF-α in macrophages (Ajjampur and Tan, 
2016; Lim et al., 2014). Innate immune response against Blastocystis also 
includes production of nitric oxide (Mirza et al., 2011a).   
 
Antimicrobial peptides (AMPs) are elements of innate immunity (Peters et al., 
2010). This group of small molecules have wide-spectrum of activities and 
pathogens in general do not develop resistance against them. The mechanism of 
action by direct killing is by forming pores on the membrane of pathogens which 
may cause leakage of cytoplasmic contents. Some AMPs are also known to bind 
to intracellular targets and inhibit cellular processes (Li et al., 2012). AMPs can 
also serve as link between innate and adaptive immunity (Wiesner and 
Vilcinskas, 2010).  
 
The objective of the experiments outlined below was to determine the 
susceptibility of Blastocystis against AMPs which are found in the colon and 
secreted by epithelial cells. LL-37, hBD-1 and hBD-2 were chosen because they 
are found in the colon and are secreted by epithelial cells (Table 1.1). These 




2.2 Material and Methods 
 
2.2.1 Parasite cultivation and ethical approval 
 
Nine (9) Blastocystis isolates (Chen et al., 1997; Ho et al., 1993; Wong et al., 
2007) previously axenized representing 3 STs (ST1, ST4 and ST7) were used 
in the experiments. The isolates were cultivated in Iscove’s modified 
Dulbecco’s medium (IMDM) (ThermoScientific) supplemented with 10% 
horse serum (Gibco). Culture media were transferred in 12-ml culture tubes 
(ThermoScientific) at 8-9 ml volume. These were pre-reduced in anaerobic jars 
(Oxoid) for at least 18 h at 37°C using anaerobic gas packs (Oxoid) before 
inoculation with Blastocystis. Cultures were maintained in the same conditions.  
 
Blastocystis isolates used in this study are maintained at the microbial collection 
of the Department of Microbiology and Immunology, Yong Loo Lin School of 
Medicine at the National University of Singapore (NUS). Isolate B, C, E, G and 
H were obtained from stool samples of patients admitted at the Singapore 
General Hospital in the 1990’s before NUS established and Institutional Review 
Board (IRB). Isolates NUH2 and NUH9 were cultivated in 2007 from fecal 
samples submitted for routine health screening.  Ethical approval was obtained 
from National Health Group IRB before project commencement and all samples 
were anonymized. Isolates WR1 and S1 were isolates and cultivated from 





2.2.2 Subtyping of Blastocystis isolates  
 
The isolates were previously genotyped using primers in a polymerase chain 
reaction (PCR) assay based on the organism's small sub-unit ribosomal RNA 
(SSU rRNA) (Noël et al., 2005; Wong et al., 2007). To further confirm ST 
identity, another PCR assay using mitochondria-like organelle (MLO) (Poirier 
et al., 2014) gene fragments were used. Total DNA were extracted from 1 × 106 
cells using Qiagen DNA stool kit (Qiagen) following the manufacturer's 
instructions. PCR was perfomed using Q5 High-Fidelity 2× Master Mix (New 
England BioLabs) with 500 ng of DNA sample. All PCR runs were completed 
using BioRad iQ5 thermocyler. PCR products were sequenced, and then 
compared to information found in National Center for Biotechnology 
Information (NCBI) (USA) nucleotide sequence database to confirm subtype 
identities. Specifically, these were isolates NandII (ST1), DMP/02-328 (ST4) 
and B (ST7). A phylogenetic tree was generated from gene sequences from 
representative isolates using DNADIST 3.5c. Proteromonas lacertae gene 
sequences were used as outgroup.  
 
2.2.3 AMP susceptibility screening  
 
To determine the susceptibility of the 9 Blastocystis isolates to various human 
intestinal AMPs, a high throughput viability assay developed by Mirza et al. 
(Mirza et al., 2011a) was applied. Briefly, flat-bottom 96-well plates (Greiner) 
were used with each well containing 0.5 × 106 Blastocystis cells. AMPs human 
beta-defensin 1 and 2 (hBD-1, hBD-2) and LL-37 were dissolved in complete 
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medium with concentrations ranging between 0 to 50 μM. After 24 h incubation 
in anaerobic conditions at 37°C, resazurin dye (Sigma-Aldrich) at 5% final 
dilution was added and incubated for another 3 h in anaerobic conditions at 
37°C. Reading of fluorescence was taken at 550 nm excitation and 570 nm 
emission wavelengths using Tecan Infinite F200 microplate reader. Synthetic 
AMPs at 95% purity were obtained from Singapore Advanced Biologics. The 
experiments were done in triplicates. 
 
2.2.4 Susceptibility of Blastocystis to AMPs and determination of IC50  
 
Half maximal inhibitory concentration (IC50) values were calculated based on 
the relative fluorescence units of resazurin after incubation with AMP-treated-
Blastocystis cultures. Using GraphPad Prism software, non-linear regression 
analyses were performed with the AMP concentration transformed into log-
scale. 
 
2.2.5 Statistical analyses 
 
Statistical analyses in all the chapters in this study comparing variables and 
determination of significance were performed using ANOVA and Student’s t-









2.3.1 Blastocystis isolates subtyping 
 
Subtype identities of 9 Blastocystis isolates were confirmed (Fig. 2.1 A) using 
PCR assay based on the parasite’s SSU rRNA and MLO gene fragments. MLO 
gene sequences from selected isolates from each ST were used to generate a 
cladogram using Neighbor-Joining/UPGMA method version 3.6a2.1 after 
aligning the sequences using ClustalW Multiple alignment (Thompson et al., 
1994) (Fig. 2.1 B). DNA sequences from GenBank of known Blastocystis STs 










Fig 2.1. 2% Agarose gel showing amplified MLO gene fragments from various 
Blastocystis isolates. Each ST has a unique band size and they were of the 
expected sizes based on sequence data from NCBI nucleotide database. 
Blastocystis ST1, ST4 and ST7 isolates would show 477, 518 and 536 bp sizes, 
respectively (A). Blastocystis isolates representing different STs clustered with 
isolates with known STs in a cladogram generated using the parasite’s MLO 







2.3.2 Susceptibility of Blastocystis to AMPs and determination of IC50 values 
 
A resazurin-based assay was used to determine the susceptibility of Blastocystis 
against three AMPs secreted by intestinal epithelial cells. Resazurin is a 
compound that fluoresces when oxidized. It is useful for measuring the 
metabolic activity of cells in culture. This was used to develop drug-sensitivity 
assays on Blastocystis cultures (Mirza et al., 2011b). The same procedure was 
used to test the susceptibility of Blastocystis to different AMPs secreted by 
epithelial cells lining the intestines. After incubation of Blastocystis with 
synthetic AMPs, the fluorescent values which reflects the cultures metabolic 
activity were measured and plotted to generate graphs (Fig. 2.2). Linear 
regression analyses were performed to determine IC50 values of each AMP 
(Table 2.1). hBD-1 did not inhibit Blastocystis while hBD-2 was only effective 
against ST4 isolates. Human beta-defensin 1, at 50 µM concentration, did not 
affect the activity of all Blastocystis isolates used in this study representing 3 
STs. Human beta-defensin 2 was only effective on Blastocystis ST4 isolates 
(Table 1) at less than 50 µM concentration. In contrast, LL-37 displayed broad 
activity on all Blastocystis isolates representing 3 STs. LL-37 was found to 
inhibit the activity of 9 Blastocystis isolates at less than 50 µM concentration 
(Table 1). There was, however, variation in the IC50 values for all the STs tested. 
At less than 10 µg/ml concentration, LL-37 was found to decrease the growth 
of Blastocystis ST1 and ST4 isolates by half. On the other hand, more than 20 
µg/ml concentration is needed to decrease the growth of Blastocystis ST7 
























































Fig. 2.2. Representative graphs showing relative fluorescence units (RFU) of 
Blastocystis isolates ST1-NUH9, ST4-WR1 and ST7-B treated with different 




















Table 2.1 Half maximal inhibitory concentration (IC50) of hBD-1, hBD-2 and 
LL-37 on Blastocystis STs.  
 
Subtype Isolate HBD-1 (µM) HBD-2 (µM) LL-37 (µM) 
ST1 
NUH2 > 50 > 50 6.0 
NUH9 > 50 > 50 4.7 
ST4 
WR1 > 50 11.4 3.2 
S1 > 50 5.0 5.4 
ST7 
B > 50 > 50 42.6 
C > 50 > 50 23.4 
E > 50 > 50 23.2 
G > 50 > 50 27.7 







There have been numerous studies showing the effectiveness of AMPs against 
bacterial, fungal and even viral pathogens. Few, however, are studies on AMPs’ 
action on protozoan parasites. A review on the effect of AMPs against two 
neglected tropical diseases, leishmaniasis and malaria, outlined both the 
positive and negative aspects on using AMPs against these protozoans (Torrent 
et al., 2012). The pore-forming ability of AMPs may not be effective against all 
similar parasites down to all the stages of their respective life cycles. The 
developmental stages of these organisms may involve variations in cell 
membrane and cell wall structure so this may include changes in charges of the 
surfaces of the cells. As mentioned, hydrophobicity is an important factor in the 
binding of AMPs in membranes (Yin et al., 2012) and it is interesting to know 
if AMP can widely affect all life stages of the parasite. On the other hand, 
several forms of a particular parasite afford multiple targets of AMPs and other 
drugs. This is an advantage especially in terms of the broad-spectrum activities 
of AMPs (Torrent et al., 2012). On the use of AMPs for treating Blastocystis 
infections, one study found analogs of an anuran skin peptide called magainin 
effective against Blastocystis hominis, Trypanosoma cruzi and Entamoeba 
histolytica (Huang et al., 1990). This study was reported more than two decades 
ago and the mechanism of AMP-mediated killing was not identified. It showed 
however that this AMP could disrupt the cell membrane leading to leakage of 




Blastocystis is widely considered a commensal thus the search for drugs that 
could eradicate the organism from human hosts did not progress rapidly. 
Infected but asymptomatic individuals may forego therapy but it is suggested 
that patients showing gastrointestinal and dermatologic symptoms undergo 
chemotherapy (Coyle et al., 2012). The usual drug of choice to treat Blastocystis 
infection is metronidazole, which is considered standard for many protozoan 
infections (Kurt et al., 2016). However, there were reports on the failure of this 
drug to remove Blastocystis from infected hosts and several subtypes have been 
identified as resistant to metronidazole treatment (Engsbro and Stensvold, 2012; 
Mirza et al., 2011a; Roberts et al., 2014a). There is a need therefore to find 
alternative strategies to treat Blastocystis infections. This study explored the 
potential of using AMPs to prevent further pathologies which are potentially 
caused by Blastocystis infection. AMPs’ activities include membrane pore 
formation which may cause cell death directly, or allow other molecules to pass 
through the membrane and bind to intracellular targets (Peters et al., 2010). In 
the latter, AMPs could make classical drugs more effective. There were also 
studies on how to develop AMP-based antibiotics (Hancock and Sahl, 2006). 
AMPs found to be effective against Blastocystis could serve as templates for 
designing new and more effective drugs. 
 
Out of the three endogenous AMPs tested, only a cathelicidin peptide had a 
broad activity against all the isolates while defensins only affected ST4 isolates. 
This, however, does not indicate that defensins fulfill no roles in Blastocystis 
infections. Synergistic effect of combination of AMPs may be common 
occurrence in immune responses against infection (Yu et al., 2016). It would be 
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interesting to study further if defensins and cathelicidins could act 
synergistically against Blastocystis by combining both AMPS in various ratios 















Cellular Effects of LL-37 
on Blastocystis Subtypes 







LL-37 is the C-terminal 37 amino-acid sequence fragment of cathelicidin 
antimicrobial peptide. Cathelicidin is a family of peptides and found in many 
mammalian species. At present, only one peptide has been identified so far in 
humans that belong to this family (Fabisiak et al., 2016). Cathelicidin is 
synthesized as a preproprotein ending up as a propeptide. It is processed by 
proteases and the fragment LL-37 is released. LL-37 assumes a helical structure 
in physiological pH, salt concentration and temperature (Kahlenberg and 
Kaplan, 2013; Vandamme et al., 2012).  
 
In bacteriological studies, as well as fungal studies, LL-37 was found to cause 
membrane disruption. The exact mechanism of this process by LL-37 has not 
been elucidated. There are three models, however, which were proposed on the 
mechanism of AMPs to produce pores on membranes (Brogden, 2005; Huang 
et al., 2004; Oren and Shai, 1998). The barrel-stave model projects that the 
peptides can form barrel-shaped holes across the membrane. The peptides are 
oriented in such a way that their hydrophobic regions align with the lipid core 
region of the membrane. This has been determined in at least one AMP 
(alamethicin). In the toroidal-pore model, a “barrel-hole” is also formed but as 
a result of the peptides forcing the lipid bilayer to bend continuously towards 
the pore. In contrast to the barrel-stave model, the “barrel” is lined both by the 
peptides and the lipid heads of the membrane. The carpet model, on the other 
hand, proposes that peptides form a “carpet” on the membrane. The peptides are 
oriented parallel to the membrane. At high concentration, the peptide acts like 
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a detergent leading to the formation of micelles made up of lipid bilayer 
components. This disrupts the membrane which results into cytoplasmic 
leakage (Brogden, 2005). A study using Fourier-transform infrared 
spectroscopy indicates that the carpet model could be the mechanism for pore 
formation of LL-37. One reason is that LL-37 does not completely insert  into 
the membrane as required in the two other previous models (Oren et al., 1999). 
 
Using resazurin-based assay as discussed in Chapter 2, it was found that among 
all the AMP’s tested, only LL-37 was effective in inhibiting all Blastocystis 
isolates representing 3 STs. However, the manner by which LL-37 acts on the 
parasite was not determined. In this series of experiments, the direct killing 
effect of LL-37 by lysis of the parasite was investigated using propidium iodide 
(PI) staining.  PI is a viability dye which cannot penetrate intact membranes. 
Three Blastocystis isolates were used to represent 3 STs: ST1-NUH9, ST4-WR1 
and ST7-B. LL-37 exerted a deleterious effect on all 3 STs but ST7 isolates 
showed relative resistance as evidenced by higher IC50 values compared to both 
ST1 and ST4 isolates. It is therefore interesting to determine whether the lysis 
of Blastocystis membrane from three different STs would be dissimilar as well 
when treated with LL-37. 
 
In this chapter, membrane disruption was investigated for three different 
isolates of Blastocystis using PI-staining and flow cytometry. Scanning electron 
microscopy was also used to look closely at certain morphological changes 




3.2 Materials and Methods 
 
3.2.1 Parasite cultivation. (See Chapter 2) 
 
3.2.2 Viability staining and flow cytometry  
 
Propidium iodide (PI) (BioVision) was used to stain Blastocystis cells to assess 
viability after LL-37 treatment. Blastocystis ST1-NUH9, ST4-WR1 and ST7-B 
isolates (1 × 107 cells/ml) were treated with LL-37 at 0, 10 and 100 µg/ml 
concentrations for 1 h. Necrotic control was added as a positive control. This 
was achieved by heating the cells at 80ºC for 15 mins. PI was then added to the 
cell suspension according to the manufacturer’s instruction. Cells were then 
analyzed using LSRFortessa (BD Biosciences). Data analysis was done using 
Summit software version 4.3 (Dako). 
 
3.2.3 Time-lapse microscopic imaging 
 
Blastocystis cells were treated with 100 µg/ml LL-37. Aliquots were dropped 
onto glass slides and observed under Olympus BX60 light microscope. Images 
were taken every 5 min.  
 
3.2.4 Scanning electron microscopy  
 
The effect of LL-37 peptide on Blastocystis membrane and surface coat were 
visualized using scanning electron microscopy (SEM). Blastocystis cells at 1 × 
38 
 
106 cells/ml density were treated with 100 µg/ml LL-37. These cells together 
with control were fixed overnight with 4% glutaraldehyde in PBS. The cells 
were then washed and attached to 0.1% poly-L-lysine-treated cover slips for 30 
mins. The cells were dehydrated with increasing concentration of ethanol. The 
coverslips with attached cells were placed in critical point dryer (Balzers CPD 
030) for carbon dioxide infiltration. After drying, the cover slips were coated 
with 5-10 nm of gold in a sputter coater. The cells were visualized in a JEOL 




3.3.1 LL-37 disrupts Blastocystis cell membrane  
 
Three isolates (ST1-NUH9, ST4-WR1 and ST7-B) each representing a 
particular subtype were incubated with 0, 10 and 100 µg/ml LL-37 for 1 h and 
analyzed for membrane disruption by staining with PI. The proportion of cells 
with PI stain was determined by flow cytometry. All three isolates showed 
increase in proportion of permeabilized cells as the concentration of LL-37 
increased. At 100 µg/ml LL-37, more than 50% of the Blastocystis ST1-NUH9 
and ST4-WR1 cells had PI-staining while only 36% of that in ST7-B isolate 














Fig. 3.1. LL-37 caused disruption of Blastocystis cell membrane. PI-staining 
and flow cytometry was used to detect cells with permeabilized membranes. 
Graphs show proportion of PI-stained cells in ST1-NUH9, ST4-WR1 and ST7-
B populations after incubation with 0, 10 and 100 µg/ml LL-37 for 1 hour. 
Necrotic condition was used as positive control for PI-staining. This was 
attained by heating Blastocystis cells for 15 min at 80ºC. There is an increase in 
proportion of permeabilized Blastocystis at higher concentration of LL-37. ST7-
B isolate showed relative resistance to LL-37 compared to both ST1-NUH9 and 





3.3.2 Time-lapse images of LL-37-induced lysis of Blastocystis 
 
Time-lapse micrographs showed that as early as 5 minutes of incubation of 
Blastocystis ST7-B isolate with the peptide, smaller cells were already 
undergoing lysis. Bigger cells were observed being lysed after 20 minutes. 
Before complete lysis, vesicles were seen forming in a few sections of the cell 
membrane (Fig. 3.2). The cells appeared to flatten as well. In addition, the 
membrane-disruptive effect of LL-37 on a ‘resistant’ isolate (ST7-B) was 
slower compared to a ‘sensitive’ isolate (ST4-WR1). Flow cytometry analysis 
showed that more than 30% of ST4-WR1 had PI-staining at 15 min treatment 
of LL-37 while it took 30 min of treatment for ST7-B cells to reach this 











Fig. 3.2. Time-lapse images of Blastocystis ST7-B cells treated with 100 µg/ml 
LL-37 (upper row) and control (lower row) (A). Images were taken every 5 
minutes. Arrows point to cells undergoing lysis. Cells lysed as early as 5 
minutes after addition of LL-37 (white arrow). Time course lysis experiments 
using PI-staining and flow cytometry were also done (B). Graph show that the 




3.3.3 Scanning electron micrographs of LL-37 treated Blastocystis 
 
Scanning electron micrographs of normal Blastocystis cells show the typical 
spherical shape particularly for Blastocystis ST1-NUH9 and ST7-B isolates 
(Fig. 3.3). Blastocystis ST4-WR1 cultures also showed slightly flattened cells. 
Blastocystis surface coat appear as rough, uneven covering of the cells. When 
treated with LL-37, Blastocystis ST1-NUH9 cells appear flattened and irregular. 
A few large pores were observed as well. ST4-WR1 cells appeared fragmented 
and loss of sphericity. ST7-B isolates also exhibited large holes when treated 
with the peptide. There also appeared smaller structures, which are probably 























Fig. 3.3. Blastocystis membrane exhibited pores of various sizes when treated 
with LL-37 for 1 h. Scanning electron micrographs also showed cells assuming 
irregular shapes when treated with the peptide. The white arrows point to 
possible large membrane pores that could lead to cytoplasmic leakage. LL-37-







This series of experiments showed that LL-37 causes membrane disruption in 
Blastocystis.  The experiments also showed the fast killing action of LL-37 as 
seen in other treatment studies of bacteria and fungi (Bucki et al., 2010; Ordonez 
et al., 2014). In conjunction with the results in resazurin-based assay, LL-37 
exerted lytic effects on all Blastocystis STs but ST7 isolates were less affected 
as shown by the lower proportion of PI-stained cells after treatment (Fig. 3.1). 
Moreover, the effect of membrane disruption was slower in a ST7 isolate 
compared to a sensitive ST isolate (i.e. WR1). Blastocystis STs exhibited 
various biological differences. For example, ST7-B isolate was significantly 
bigger in size compared to ST4-WR1 isolates. The former also has a slower 
growth rate compared to the latter. These and other factors may be responsible 
for the variation in AMP susceptibility and lysis rate among Blastocystis STs. 
Some of these factors will be considered later.  
 
The fact that LL-37 caused permeabilization to Blastocystis indicates that the 
peptide has affinity to the parasite’s membrane. It may also suggest that the 
surface coat does not completely protect the parasite from AMP attack by either 
preventing AMP binding to the membrane or shielding the negative charges in 
the membrane. In this context, the membrane of Blastocystis, a eukaryote, is 
similar to that of prokaryotes which makes the parasite susceptible to direct 




SEM images showed extensive morphological changes in Blastocystis treated 
with LL-37. The holes in the membrane were of different sizes. There were also 
other structures which could be cytoplasmic contents of the parasite. In bacteria, 
blebs were seen forming when treated with an AMP called SMAP29, a helical 
peptide similar to LL-37 (Brogden, 2005). In SEM images, these were difficult 
to find since the appearance of normal Blastocystis surface is rugged and 
features tiny bleb-like structures. It would require therefore a more specific 
approach to observe the process of membrane permeabilization in Blastocystis 
from beginning to end.  
 
Going further, it would be interesting to study if inhibitors or proteases directed 
against LL-37 could abrogate ultrastructural changes in Blastocystis arising 
from LL-37 treatment. It is known that an analog of LL-37 with shorter 
sequence can still have an antimicrobial activity (Wang, 2008). LL-37 
fragments cleaved by an E. histolytica protease was also found to maintain its 
antibacterial property (Cobo et al., 2012).  Finding out if these observations 
could also apply to Blastocystis is compelling especially when considering 
microbiome-parasite interactions. Another technique that could be considered 
is the use of antibodies directed against LL-37. This could be an alternative in 










Chapter 4  
 
Cellular Effects of LL-37 
on Blastocystis Subtypes 







The previous chapters discussed the effects of AMPs (particularly LL-37) on 
the growth and membrane integrity of Blastocystis. This chapter focused on the 
phenotypic changes caused by LL-37. The difficulty in this approach was that 
Blastocystis has a number of morphological forms, which are purported to have 
reproductive relevance (Govind et al., 2002, 2003; Tan and Stenzel, 2003; 
Windsor et al., 2003). These morphological forms observed both in culture and 
clinical samples still must be evaluated, however. For example, multivacuolar 
forms have been thought to be Blastocystis undergoing multiple fission or 
schizogony similar to what happens in other protozoan parasites (Govind et al., 
2002). There were also suggestions that amoeboid forms may undergo 
plasmotomy (Yamada and Yoshikawa, 2012). Whether or not granular forms 
have specific biological functions is still yet to be discovered (Zhang et al., 
2012). There was also a report on granular amoeboid forms expelling small 
granules in xenic cultures (Zhang et al., 2012). The authors however did not 
investigate further if these granules represent reproductive stages. Currently, 
only binary fission has been accepted as a mode of reproduction in Blastocystis 
since it can be readily observed under microscopy. Other investigators also 
suggested that other forms may be artefacts and do not represent reproductive 
stages (Clark et al., 2013; Tan, 2008; Vdovenko, 2000). There is, however, an 
interest on looking for alternative modes of reproduction. For some, binary 
fission alone could not explain the high number of cells in cultures and in fecal 
specimens (Govind et al., 2002). Just like the parable of the blind men and the 
elephant, various groups have reported on distinct forms without taking into 
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consideration the morphological complexity of the parasite. This often led to 
biases and confusion in the Blastocystis field. There is therefore a need to 
evaluate morphological forms exhibited by Blastocystis in terms of their 
biological importance. 
 
In this chapter, an imaging flow cytometer was used to survey the 
morphological characteristics of 3 Blastocystis isolates representing 3 subtypes 
(ST1, ST4 and ST7).  The Amnis ImageStream Mark II can acquire thousands 
of images in a sample. These images can then be analyzed based on specific 
characteristics such as size, aspect ratio, fluorescence staining intensity, etc. 
This technique was applied to characterize morphological features such as 
shape, size, granularity and location of nuclei that can identify unique 
population characteristics in each subtype. Fluorescence dyes were also used to 
visualize cellular structures such as vacuoles and nuclei. The proportions of 
cells showing these features were then calculated. This part of the study was the 
first to provide a comprehensive and unbiased overview of the various 
morphological forms of Blastocystis in culture and shed new light on the roles 
of certain forms of the parasite. After these baseline assessments, the technique 
was applied to LL-37-treated Blastocystis cultures. The flow imaging cytometry 
was used to visualize and quantify the localization of LL-37 molecules on the 
surface of Blastocystis and determine the proportion of permeabilized cells 
among those with bound LL-37. With this, it was possible to compare the 
affinity of LL-37 to membrane surface as well as the effect of surface-bound 




4.2 Materials and Methods 
 
4.2.1 Parasite cultivation. (See Chapter 2) 
 
4.2.2 Fluorescence staining and imaging flow cytometry 
 
In order to analyze cultures at the same stage of growth, 2-day old cultures of 
Blastocystis isolates WR1 and B and 7-day old culture of isolate NUH9 were 
harvested. The cells were washed twice by centrifugation at 1,000 × g using 
warm PBS. 2 × 107 cells in 200 µL PBS were collected into 1.5 µL microtubes. 
The cell suspensions were then stained with 1 µg/mL PI (BioVision), 5 µM 
carboxyfluorescein succinimidyl ester (CFSE) (Life Technologies) and 1 
µg/mL Hoechst 33342 (Life Technologies) for 15 mins. PI stain was used to 
select for viable and non-viable cells. Cells will only take up PI when there is 
membrane disruption. CFSE is used in proliferation studies and is found to stain 
vacuolar compartments of Blastocystis (Wu et al., 2014). Hoechst stains the 
DNA and is useful for cell-cycle analysis. Actively dividing cells will have 
higher emission while dying cells undergoing DNA fragmentation will have 
lower fluorescence readings. The cells were then washed to remove excess 
stains and fixed in 2% formaldehyde. Single stained cells were also prepared 
and used to create a compensation matrix. Blastocystis cell suspension heated 
to 80OC for 15 mins was used as positive control for PI-staining. Amnis 
ImageStream MarkII (Merck Millipore) with 4-laser attachment (375, 488, 561 
and 642) was used to acquire Blastocystis cell images. 2,000 events were 
obtained with low flow speed at 60× magnification. Images at extended depth 
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of field (EDF) setting were also acquired. EDF involves deconvolution to obtain 
highly focused images. Gating strategy involved selecting for focused cells 
using RMS gradient values, then for single cells using brightfield aspect ratio 
(Fig 4.1). Viable Blastocystis cells were identified as those without PI-staining. 
Cell shapes were characterized using aspect ratios from brightfield and CFSE 
staining. Acquisition was done using 3 different batches of cultures. Analysis 












Fig 4.1.  Initial gating strategy to analyze Blastocystis cells. Cells were gated 
for focused cells using brightfield channel, then selection of single cells using 
aspect ratio and area units, and finally to classify viable and non-viable cells 
using PI-staining characteristics. The above graphs show the analysis for 
Blastocystis ST1-NUH9 isolate (A). Subsequent analyses made use of features 
arising from Hoechst and CFSE staining characteristics as well as features from 





4.2.3 LL-37 treatment of Blastocystis 
 
Blastocystis cultures of NUH9, WR1 and B isolates were harvested at the log 
phase of their corresponding growth curves. NUH9 has the slowest growth rate 
and cultures from this isolate were harvested after 7 days. Two-day old WR1 
and B cultures were collected and used in the experiments. Cell suspensions 
with of 1 × 107 cells/ml were prepared and treated with LL-37 at 0, 10 and 100 
µg/ml concentrations for 1 h. The cells were then centrifuged and washed with 
PBS. These were the run in the imaging flow cytometer. 
 
4.2.4 Localization of LL-37 bound on Blastocystis surface 
 
LL-37 bound to the cell surface of Blastocystis were also visualized using 
imaging flow cytometry. Before running the samples, 1 × 107 cells were treated 
with 50 µg/ml LL-37 at room temperature. PI was added and the cells were 
fixed using 4% formaldehyde for 30 mins. The cells were washed twice and 
suspended in PBS. LL-37 bound to Blastocystis cell surface was probed with 
1:1000 rabbit polyclonal anti-LL37 human IgG antibody (Abcam) for 30 mins. 
Goat polyclonal secondary antibody to rabbit IgG FITC-conjugated antibody 
(Abcam) at 1:500 concentration was then added and incubated for 30 mins. All 







4.3 Results  
 
4.3.1 Round and irregularly-shaped cells found in Blastocystis STs 
 
Using imaging flow cytometry, both round and irregular shapes were found in 
all Blastocystis isolates (Fig. 4.2, 4.3). The proportion of these shapes however 
differed from one subtype to another. Viable Blastocystis ST1-NUH9 was 
exclusively round, but only 76% round (the rest are irregular) in non-viable 
cells. Viable Blastocystis ST4-WR1 and ST7-B isolates were 83% and 92% 
round-shaped, respectively. These proportions were slightly lower (82% for 







Fig. 4.2. Gating for round and irregular shapes of Blastocystis. The shapes of 
Blastocystis were selected based on aspect ratios from the brightfield channel 
(M03) and CFSE staining (M02). Viable and non-viable cells were plotted 
separately. The above graphs show the gating for Blastocystis ST1-NUH9 
isolate (A). The average proportion of round and irregular shapes found in 
cultures of Blastocystis ST1-NUH9, ST4-WR1 and ST7-B were then plotted in 
a graph (B). These were based on three separate batches of cultures and 
independent runs in ImageStream. Error bars signify standard error values. p-
values comparing the proportion of round cells between viable and non-viable 







Fig. 4.3. Blastocystis STs display various shapes from both viable and non-
viable populations. Image gallery of Blastocystis cells showing round and 
irregular shapes from viable and non-viable populations. Each cell shown in the 
brightfield view has corresponding images which display CFSE-staining, 
brightfield-CFSE composite and PI staining. The latter was used to determine 
viability. Irregular-shaped cells show elongated cells and amoeboid forms. 
Amoeboid forms with prominent pseudopodia and filamentous attachments 
were restricted to non-viable forms ST1-NUH9 and ST4-WR1. There were rare 






4.3.2 Profile of Blastocystis cells according to Hoechst staining and circularity 
 
Analysis of single Hoechst-staining was also done to further correlate 
Blastocystis shape and reproductive status. Hoechst-staining is used for cell-
cycle analysis. In general, actively dividing cells registered higher fluorescence 
compared to inert cells. The imaging flow cytometry can arrange the cells based 
on circularity which in turn is based on the images acquired using the brightfield 
channel. In all the isolates studied, round-shaped cells had higher average 
Hoechst-staining compared to irregularly-shaped cells (Fig. 4.4 B-C). This 
finding linked well with the observation using PI-staining that most irregularly-












Fig. 4.4. Round Blastocystis have higher DNA content. Blastocystis cells were 






4.3.3 Profile of Blastocystis cells according to granularity 
 
The side-scatter channel was used to measure granularity of the cells. The 
average intensity coming from the channel in all STs in non-viable cells are 
higher compared to viable cells. Cells that are more granular can be found 
mostly among non-viable cells as seen among the population with PI staining 
(Fig 4.5 A-B). Non-viable cells have wider range in terms of granularity in 
contrast to viable cells where these tend to have lower side-scatter channel 
intensity. Samples of granular cells from the three Blastocystis isolates are 





Fig. 4.5. Analysis of Blastocystis based on granularity. Blastocystis populations 
were plotted according to mean pixel intensities of both side scatter channel and 
PI staining to determine the cells' granularity and viability, respectively (A). 
Cells with higher PI staining have more granularity compared to cells with 
lower PI staining. This observation was common to all subtypes used in this 
study as shown in a graph (B). Sample images showing cells with high 
granularity among viable and non-viable populations (C). These cells may 




4.3.4 Profile of viable Blastocystis cells according to granularity and Hoechst 
staining 
 
Both the side-scatter channel and Hoechst-staining characteristics were used 
simultaneously to analyze the DNA content of viable granular cells. Dot-plots 
showed that viable granular cells tend to have higher DNA content (Fig. 4.6). 
















Fig. 4.6. Viable Blastocystis cells with high granularity have higher DNA 
content. Dot-plot shows the populations of Blastocystis cells plotted according 





4.3.5 Size range of Blastocystis isolates 
 
Using the images obtained from brightfield channel, the size ranges of viable 
cells in each of the three subtypes were determined. ST1-NUH9 and ST7-B 
isolates were bigger compared to ST4-WR1 isolates (Table 4.1). Furthermore, 
more than half (51.7%) of ST1-NUH9 cells have diameter of greater than or 
equal to 5 µm while only 37.3% of ST7-B cells have this size. ST4-WR1 cells 


































diameter ≥ 5 µm 
(%) 
ST1-NUH9 2.7-8.7 5.0 51.7 
ST4-WR1 2.2-6.2 3.6 1.7 





4.3.6 Imaging of Blastocystis showing classical morphological forms 
 
The images of classical morphological forms of Blastocystis were acquired 
using EDF function of the imaging flow cytometer. Except for the size 
differences, the three isolates showed cells each with a large vacuole that pushes 
the nucleus to the edge (Fig. 4.7). The intensity of the staining for vacuoles 




Fig. 4.7. Image gallery of Blastocystis showing classical morphological forms 
at varying sizes in the viable populations. Images were acquired using EDF 
setting of the imaging flow cytometer. Each cell is represented by two images: 
Hoechst-CFSE-staining composite and brightfield image. The nuclei were 
stained with Hoechst and the vacuole with CFSE. These round forms showed a 
single nucles located at the edge of the cell. These forms comprised more than 
half of the population in all the subtypes studied.   
66 
 
4.3.7 Imaging of rare Blastocystis multinucleated cells 
 
Blastocystis multinucleated cells were also observed using the imaging flow 
cytometer. However, only ST1-NUH9 and ST7-B populations had cells with 3 
or more nuclei (Fig. 4.8 A). There were also small structures present in the 
cultures which indicated DNA content (Fig. 4.8 B). At present, they have 












Fig. 4.8. Image gallery of rare Blastocystis multinucleated cells. The nuclei are 
visualized by Hoechst staining. The nuclei numbered more than three and some 
appeared to be concentrated in the center and not along the edges (A). Some of 
these cells also appeared to show nuclear condensation. (B) Image gallery 





4.3.8 Application of imaging flow cytometry to Blastocystis treated with LL-37 
 
With the establishment of comprehensive and baseline data on Blastocystis 
morphological forms, the same technique to achieve this was used to investigate 
LL-37-treated Blastocystis cultures. Brightfield images included round and 
irregularly-shaped cells (Fig. 4.9 A). Upon treatment with LL-37, the proportion 
of round cells decreased in the population Fig. 4.9 B). The greatest change in 
the proportion of round cells was observed in the cell suspension with the 
highest concentration of LL-37. At 10 µg/ml LL-37, the change in percentage 
of round cells was minimal. At 100 µg/ml LL-37, there was a reduction of at 







Fig. 4.9. LL-37 causes morphological changes in Blastocystis isolates. 
Blastocystis were incubated with LL-37 for 1 h and analyzed using an imaging 
flow cytometer. Images (A) show round and irregular cells as determined by 
circularity index generated by the software. Bar graphs (B) show that treatment 
of Blastocystis STs with LL-37 decreased the proportion of round-shaped cells. 





4.3.9 Localization of LL-37 to Blastocystis surface 
 
An imaging flow cytometry was used to visualize LL-37 bound to Blastocystis 
(Fig. 4.10 A). The proportion of cells with bound LL-37 is higher in ST4-WR1 
isolates compared to ST7-B isolates (Fig 4.10 B). Gating for cells with bound 
LL-37, a higher percentage of ST7-B cells were found to be viable compared to 
ST4-WR1 cells (Fig. 4.10 C). Single antibody controls (primary and secondary) 








Fig. 4.10. LL-37 binds to the cell surface of Blastocystis. Images from the 
brightfield, FITC and PI channels are displayed showing both the viable and 
non-viable cells with bound LL-37 (A). LL-37 was detected using FITC-
conjugated antibodies. Viability was determined using PI-staining. Blastocystis 
ST4-WR1 had a higher proportion of cells with bound LL-37 peptide (B). 
Among the cells with bound LL-37, Blastocystis ST4-WR1 had lower viability 






In these series of experiments, analyses of three STs of Blastocystis based on 
shape, size, granularity and nuclear arrangement were done using high content 
imaging flow cytometry. The features have been used to compare one 
Blastocystis ST to another. Rare forms which could possibly point to alternative 
modes of reproduction in the parasite have also been identified. Data from this 
study provided an important and useful reference on the morphological profile 
of Blastocystis STs. The methods outlined in this study have been used to detect 
changes in Blastocystis upon treatment of LL-37.  
 
Several studies have attached significance to amoeboid forms in terms of 
reproduction and pathogenicity and these appear as irregularly-shaped cells 
(Govind et al., 2002; Rajamanikam and Govind, 2013; Windsor et al., 2003). 
These reports however did not identify the subtype of Blastocystis they have 
observed. Past studies also did not take into account the viability of these cells. 
In this study, morphological features of Blastocystis were analyzed while 
determining their viability using PI-staining. Irregularly-shaped cells in ST1 
were found to be non-viable and therefore may not have any biological 
significance in this particular Blastocystis subtype. Isolates from ST4 and ST7, 
on the other hand, have viable irregularly-shaped cells. This irregularity could 
be due either to the cells' elongated shape or due to amoeboid features such as 
pseudopod-like structures. Analyses of the images showed that these amoeboid 
forms were rare among viable populations as most irregularly-shaped cells 
(especially in ST4) were elongated. In ST1 and ST4, these forms were more 
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numerous but all were non-viable. Analysis of cells from viable ST7 isolates 
showed only one cell (out of ~1000 cells) that could be characterized as 
amoeboid (Fig. 4.3). 
 
Aside from the round vacuolar forms, round granular forms were also 
commonly observed in clinical samples and in cultures (Tan, 2008; Zhang et al., 
2012). Vdovenko (2000) observed that these forms can naturally arise from 
vacuolar forms possibly by environmental exposure or fixation artefact. A more 
recent study has also mentioned this phenomenon (Zhang et al., 2012). These 
findings were consistent among the 3 STs studied (Fig. 4.4 B). Nevertheless, 
cells that were more granular can also be found among viable cells. Analysis of 
the images suggests that there exist two populations of granular cells: true 
granular cells and those that are degenerating (Fig. 4.4 C) as reported previously 
(Clark et al., 2013; Vdovenko, 2000). In addition, granularity of these dying 
cells may be due more to environmental exposure rather than caused by fixation 
since the same proportion of granular forms have been observed in both fixed 
and unfixed samples. 
 
The diameter of Blastocystis vacuolar forms have been estimated to be between 
2 and 200 µm (Tan, 2008). A study (MacPherson and MacQueen, 1994) 
indicated that the diameter of 80.8% of the Blastocystis they observed fell 
between 5 and 15 µm. That study, however, was published before the 
genotyping era and so the particular ST of the isolate is unknown. Mirza et al. 
have previously reported differences in sizes between ST4 and ST7 isolates 
using flow cytometry (Huang et al., 1990). In that study, the diameter of 
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majority of Blastocystis cells after 48 hours of culture were 6 to 10 µm and 3 to 
6 µm for ST7 and ST4 isolates, respectively. The calculations made for ST4 in 
this study mirrors that of the previous report. However, the measurement in this 
study for ST7 is smaller (Table 4.1). The previous study has determined the 
sizes indirectly using known-sized beads and set them as standards for the 
forward scatter channel values in flow cytometry. This study however makes 
use of actual images of the cells and converting the pixel measurements to 
micrometers. Using the present technique, it was possible to exclude the 
doublets from the measurement by confirming the arrangement using the 
images themselves. There might be bigger-sized cells depending on the type and 
age of samples as well the amount of initial inoculum. The analyses highlight 
the importance of taking into account the subtype used in any morphological 
studies. The size range of Blastocystis is not as wide as between 2 and 200 µm, 
but narrower when ST identity is established. In addition, it was possible to 
measure just the viable cells alone as the non-viable cells may feature 
degenerating cells and assume irregular shapes (Fig. 4.3).  
 
Hoechst staining and the EDF setting of the imaging flow cytometer was used 
to analyze nuclear arrangement of viable Blastocystis cells. More than 80% of 
the population from the three subtypes studied featured 1-2 nuclei (Fig. 4.7) 
located at the edge of the cells. ST4-WR1 isolates all feature one or two nuclei 
(and not more). This reflected the previous observation (MacPherson and 
MacQueen, 1994) whereby 98.4% of the cells have a similar arrangement. This 
study therefore supported the classical representation of Blastocystis. More 
infrequently, in the other STs (1-2% in ST1 and 2-8% in ST7), other nuclear 
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features were observed. These cells either showed more than 2 nuclei or that the 
nucleic acid stain covered a large area of the cell (Fig. 4.8). The latter showed 
an apparent nucleic acid condensation which could represent cells about to 
undergo binary fission. Surprisingly, multinucleation have been identified only 
in round cells in these two subtypes. No evidence was found to support 
alternative modes of reproduction such as plasmotomy and budding in 
Blastocystis as suggested by others (Govind et al., 2002; Yamada and 
Yoshikawa, 2012; Zhang et al., 2012) since multinucleation was not observed 
in irregularly-shaped viable cells. Some of the multinucleated cells showed the 
nuclei located in the center of the cell with the size of the central vacuole 
diminished (as indicated by lower intensity of CFSE staining). If this was a 
reproductive stage, it may be an evidence of a multiple fission event in 
Blastocystis as suggested (Suresh et al., 1994). Small structures containing 
nucleic acid have also been observed. These structures were rare (2-4% of viable 
cells). They also do not appear to have vacuoles as indicated by low CFSE 
staining but consist mainly of nucleic acid material in its compartment. 
Experiments in this chapter did not determine whether these structures originate 
from bigger and multinucleated cells. It may also be possible that these 
represented starving cells or a state where Blastocystis sheds off its vacuole. 
 
Finally, after morphological forms have been assessed for relevance, the method 
and data obtained were applied to LL-37-treated Blastocystis cells. LL-37, as 
determined from the previous chapters, caused lysis of Blastocystis cells. SEM 
images also showed deformation and breakage of cells. The imaging flow 
cytometry analyses also showed this phenomenon occurring in the parasite. The 
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advantage of this method from SEM was that whole populations of the organism 
can be analyzed. It was possible to evaluate the extent of the effect of LL-37 on 
Blastocystis cells in cultures and calculate the proportion of the cells being 
affected. The ability to observe the cells in this way also made it possible to 
evaluate the viability of Blastocystis using morphological changes alone. In 
addition, the imaging flow cytometry was also able to identify Blastocystis cells 
with bound LL-37 and determine their corresponding proportion in the 
population (Fig. 4.10). This was made possible using fluorescence-tagged 
specific antibodies. As the results showed, Blastocystis ST4-WR1 have higher 
proportion of cells bound with LL-37 compared with ST7-B when these two 
isolates were treated with the same peptide concentration (Fig. 4.10 B). This 
difference in LL-37 affinity in different surfaces of Blastocystis isolates may be 
associated with the differences in susceptibilities of the isolates to AMPs. As 
the peptides are attracted to negatively-charged surfaces, structures outside the 
Blastocystis cell membrane may modify these charges or make the membrane 
less exposed to AMPs. It would therefore be interesting to have a closer look on 
the surface coat of Blastocystis and its function in the survival of the parasite. 
Specifically, its ultrastructure and its residues need to be identified and 
characterized. These may provide clues on whether the coat can trap AMPs or 






















Previous chapters have shown the broad activity of LL-37 on Blastocystis. 
However, the STs showed variations in their sensitivity to the peptide. 
Blastocystis isolate B which belongs to ST7 showed relative resistance to LL-
37 compared to ST1 and ST4 isolates as shown in the IC50 values and flow 
cytometry with PI staining data. In this chapter, the factors which contributes to 
the resistance of ST7-B isolate will be explored. 
 
While developing resistance against AMPs is a rare phenomenon, several 
bacterial species possess the ability to mitigate the effects of AMP. In a review 
paper (Cole and Nizet, 2016), several of these factors were highlighted. Briefly, 
these factors include: modification of the surface charges to decrease binding 
affinity of AMPs; use of surface molecules to trap AMPs; secretion of proteases 
that can degrade AMPs; efflux systems that pumps out AMPs and prevent them 
from binding to intracellular targets; induction of regulatory networks that 
synergistically protects the bacteria from AMP attack, and; suppression of AMP 
expression. Since AMPs effect of unicellular eukaryotic parasites are few, only 
several of these factors have been investigated.  
 
In this chapter, resistance factors of ST7-B isolate have been identified. 
Experiments made use of sensitive strains to present comparisons. Blastocystis, 
as a eukaryotic unicellular organism, possesses complex surface structure. It’s 
known to secrete proteases which affects the immune responses. It is also 
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significantly bigger in size compared to prokaryotic organisms. These factors 
then could lessen the effects of AMPs particularly LL-37. 
 
5.2 Materials and Methods 
 
5.2.1 Parasite cultivation (see Chapter 2) 
 
5.2.2 LL-37 degradation and viability assay 
 
Blastocystis ST7-B and ST4-WR1 excretory-secretory products (ESPs) were 
harvested from 24-h cultures. The cultures were washed twice in serum-free 
IMDM. The cells were then incubated for 2 h in pre-reduced serum-free IMDM 
at 37ºC in anaerobic conditions at 1 × 108 cells per ml of IMDM.  Culture 
supernatants were then collected by centrifugation at 1,000 × g for 10 min and 
filtered twice using 0.2 µm-pore filters (Millipore). Blastocystis secreted 
products were stored at -80ºC until use.  The effect of Blastocystis ESPs on 
peptide integrity was quantitatively determined by ELISA. Briefly, 50 µl of LL-
37 at 2 µg/ml concentration were coated onto each well in flat-bottom 96-well 
Nunc Maxisorp plates for 18 h at 4ºC. Coated LL-37 were exposed for 2 h to 
Blastocystis ESPs alone or ESPs previously incubated for 6 h with 1× Halt 
protease inhibitor cocktail (BioRad) at 37ºC. The wells were then washed with 
PBS and concentration of intact LL-37 were determined using ELISA outlined 
above. LL-37 peptide solution previously incubated with Blastocystis ESPs 
were also used for treatment of Blastocystis cultures. Viability was determined 
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using flow cytometry and PI-staining after treatment. Denatured ESPs were also 
used in this assay which entailed heating the ESPs for 15 min at 95ºC. 
 
5.2.3 pH adjustment of Blastocystis culture medium  
 
Three sets of Blastocystis culture medium were prepared with different pH: 6.5, 
7.1 and 8.0. The pH of the media were adjusted using 6N HCl or 6N NaOH. pH 
measurements were made using Beckman Coulter PHI 350 pH meter. 
 
5.2.4 Transmission electron microscopy  
 
24-h cultures of Blastocystis cells (1 × 107) were harvested, washed and treated 
with 100 µg/ml cationized ferritin (Sigma-Aldrich) for 2h. Cationized ferritin 
binds to negatively-charged surfaces (26). This was useful to visualize the 
surface coat of Blastocystis by providing better contrast and maintaining its 
integrity during the preparation of cells for electron microscopy. The cells were 
then fixed overnight at 4ºC with 8% glutaraldehyde. The cells were then washed 
3 times with PBS. Post-fixation included incubating the cells with 1% osmium 
tetroxide and 1% potassium ferrocyanide in PBS for 2 h. The cells were then 
washed 3 times. The cells were dehydrated with absolute ethanol 5 times. 
Embedding was done for 48 h using London resin white. The solidified blocks 








5.3.1 Blastocystis ST7-B secretes proteases that can degrade LL-37 
 
A modified ELISA was used to determine if Blastocystis ESPs can degrade LL-
37. ESPs from ST7-B and ST4-WR1 cultures were used to represent LL-37-
resistant and LL-37-susceptible isolates, respectively. Absorbance of wells after 
incubation with ST7-B isolate’s ESP was lower compared to ST4-WR1’s (Fig. 
5.1 A). This suggests that ST7-B isolates produce proteases that can degrade 
LL-37. This degradation was inhibited when ESPs were incubated with a 
protease cocktail inhibitor prior to the degradation assay. In addition, PI staining 
was also used to determine viability of Blastocystis after treatment with LL-37 
previously incubated with ST7-B ESP (Fig. 5.1 B). The secreted proteases in 
ST7-B ESP inactivated LL-37 activity on Blastocystis. This however was 












Fig. 5.1. Blastocystis ST7-B isolate (but not ST4-WR1) excreted-secreted 
products (ESP) degrade LL-37 as shown in ELISA results (A). LL-37 peptide 
was coated on ELISA plates and incubated with Blastocystis ESP for 2 h. 
Degradation was prevented when ST7-B ESP were incubated with a protease 
inhibitor cocktail prior to incubation with the peptide. Viability experiments 
were also done using LL-37 previously incubated with ST7-B ESP (B). Graph 
shows that ST7-B ESP attenuated LL-37 activity. This was reversed when ESP 





5.3.2 Blastocystis ST7-B lowers the pH in culture and attenuates LL-37 activity 
 
The pH of complete medium for Blastocystis were adjusted and used to 
determine if it has effect on the activity of LL-37 on Blastocystis. At pH 6.5, 
LL-37 had minimal effect on Blastocystis ST7-B and ST4-WR1 isolates with 
cell count at 90% and 88%, respectively, compared to untreated cultures. At pH 
7.1, the relative resistance of ST7-B isolates was compared to ST4-WR1. Cell 
counts at this pH with LL-37 was 76% and 41% for ST7-B and ST4-WR1 
isolates, respectively, normalized to untreated cultures. At pH 8.0, ST7-B and 
ST4-WR1 cell counts were 44% and 38%, respectively, of untreated cultures. 
At this pH, the highest level of activity of LL-37 was observed which negated 
the relative resistance of ST7-B isolate (Fig. 5.2 A). The pH of Blastocystis 
culture medium after 24 hours was also determined. Blastocystis ST7-B 












Fig. 5.2. pH affects the activity of LL-37 on Blastocystis. In acidic pH, LL-37 
did not inhibit both Blastocystis STs (A) while at neutral and alkaline pH, both 
ST4-WR1 and ST7-B were inhibited by the AMP. Blastocystis ST7-B (but not 





5.3.3 Surface coat of Blastocystis  
 
India ink was used as negative stain to visualize the surface coat of Blastocystis 
cells. Most cells from ST7-B cultures showed thicker surface coats (Fig. 5.3 A-
B). To observe the surface closely, transmission electron microscopy (TEM) 
was used. Cationized ferritin was used to label negatively-charged elements in 
the cell surface. Again, TEM showed a thicker surface coat for ST7-B cells 
compared to ST4-WR1 (Fig. 5.3 C-F). The coat’s thickness in ST7-B isolates 
was almost three times than that of ST4-WR1 isolates (Fig. 5.3 G). Furthermore, 





Fig. 5.3. Blastocystis ST7-B (A, C and E) isolates have thicker and denser 
surface coats (arrows) compared to ST4-WR1 (B, D and F) isolates as shown 
using India ink as a negative stain in bright microscope (A and B), and using 
transmission electron microscope (C, D, E and F). Images from TEM was used 
to measure the thickness of the surface coat. The surface coat of ST7-B isolate 






Blastocystis spp. constitute several isolates with significant biological 
differences. In the previous chapters, susceptibility assays showed that ST7 
isolates B, C, E, G and H had higher IC50 values for LL-37 compared to both 
ST1 and ST4 isolates. Expectedly, a representative isolate of ST7 (B), required 
higher concentration of LL-37 to reach the same proportion as with ST4-WR1 
in PI-staining. These indicate some resistant factors are present in ST7 isolates. 
Blastocystis is known to secrete proteases. Particularly for ST7-B, its lysates 
were found to have high protease activities (Sio et al., 2006).  In another study, 
proteases from ST7-B isolate were specifically able to degrade IgA (Puthia et 
al., 2005). Interestingly, ST4-WR1 isolate also contain proteases which have 
the same activity. Other studies on proteases of Blastocystis focused on their 
link in cell-death pathways and inflammatory responses (Lim et al., 2014; 
Puthia et al., 2008; Yin et al., 2010). The two identified proteases in 
Blastocystis, cathepsin B and legumain, were found to act on intestinal epithelial 
cells which links them to gut disorder (Wawrzyniak et al., 2012). In this study, 
secreted proteases from Blastocystis ST7-B isolate was found to degrade LL-
37. Secreted proteases from ST4-WR1 isolate did not have this activity. It would 
be interesting to investigate on whether the two known Blastocystis proteases 
affect LL-37 activity. LL-37 can be degraded by proteases expressed by some 
pathogenic bacteria (Schmidtchen et al., 2002). Staphylococcus aureus, for 
example, secretes two different proteases that can cleave L-37 at different 
positions (Sieprawska-Lupa et al., 2004). Metalloproteases of Bacillus 
anthracis could also degrade the peptide, but these resistant factors are not 
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present in other Bacillus spp. (Thwaite et al., 2006). For another intestinal 
eukaryotic parasite, E. histolytica, a cysteine protease can also be produced that 
can degrade LL-37 (Cobo et al., 2012). In this study, the proteases present in 
Blastocystis secreted products could inactivate LL-37. This, however, was only 
present in a ST7 isolate and not in ST4 isolate. This partly explains why ST7 is 
relatively resistant to LL-37 compared to the other STs. 
 
LL-37’s antimicrobial activity is dependent on its conformation in solution 
(Johansson et al., 1998). This, in turn, is dependent on temperature, salt 
concentration and pH. Below pH 5, there is a decrease in helical structure. On 
the other hand, LL-37 helical structure is maintained at basic pH, even up to pH 
13. This was further proven in a study in which at pH 6.8, the killing of 
Staphylococcus aureus and Pseudomonas aeruginosa was mitigated (Alaiwa et 
al., 2014). In this study, the effect of acidic pH on LL-37’s activity on 
Blastocystis was investigated. After 24 hr, the pH of culture medium became 
acidic for ST7-B isolate, while it stayed neutral for ST4-WR1 (Fig. 5.2 B). The 
acidic medium in the former was enough to attenuate LL-37 activity. However, 
when the culture medium was adjusted to basic pH, even ST7-B cells became 
susceptible to LL-37 at an equal proportion as observed in ST4-WR1 
populations. In physiological setting, the low cell number of Blastocystis may 
not be enough to affect the pH of the colon. However, this could still be a factor 
in AMP resistance when the microenvironment of Blastocystis colony is 
considered. The surface coat also may trap or at least slow down the binding of 
AMPs to the membrane. If this happens, the acidic pH in the microenvironment 
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could then attenuate AMP activity by, for examples, changing the peptide’s 
structure. 
 
Blastocystis has been known to possess a surface coat that covers the plasma 
membrane and is composed of polysaccharide residues (Lanuza et al., 1996; 
Zaman et al., 1999). As mentioned, the presence of structures outside the 
bacterial membrane could provide resistance to the organism from AMP killing. 
Bacterial capsules have been found to protect bacteria from LL-37 and other 
helical AMPs (Cole and Nizet, 2016). The sugar structures trap AMPs and 
prevent them from interacting with the bacterial membrane. Or they could 
decrease the affinity of the membrane to AMP binding by modifying the net 
charge (Peschel and Sahl, 2006). Some elements in these capsules also have 
more activity. For example, Group A Streptococcus has M1 protein that traps 
and inactivates LL-37. Furthermore, this protein prevents maturation of LL-37 
by binding to cathelicidin (LaRock et al., 2015).  
 
Blastocystis’ surface coat could possibly be a resistant factor for the parasite to 
lessen LL-37 activity. Analyses of the parasite’s coat by India ink staining and 
TEM indicate that ST7-B’s has thicker and denser coat compared to ST4-WR1 
isolate (Fig. 5.3). Imaging flow cytometry also revealed that LL-37 has higher 
affinity to the surface of ST4-WR1. In addition, for the Blastocystis cells with 
attached LL-37, ST4-WR1 cells had higher proportion of dead cells (Fig. 4.10 
C). A possible explanation would be that the thicker surface coat of ST7-B cells 











Modulation of LL-37 








The previous chapters discussed the effects of LL-37 on Blastocystis isolates. 
This chapter focused on the modulation of the peptide’s expression by 
Blastocystis. This chapter aimed to complete the picture of the role of AMP in 
Blastocystis infections in the context of host-pathogen interactions. Most AMPs 
including cathelicidin/LL-37 have upregulated expression during inflammation 
and infection of the colon (Ho et al., 2013). LL-37 and other AMPs are secreted 
by epithelial cells to maintain homeostasis in the gut physiology. LL-37, like 
other AMPs have other downstream immune functions aside from being solely 
and directly antimicrobial. They can recruit other cells, provide stronger antigen 
presentation, activate regulatory networks and stimulate cytokine production 
(Jäger et al., 2013; Ostaff et al., 2013). The modulation of AMP expression by 
an invading pathogen is therefore relevant as this may provide additional 
information to explain the outcome of the infection.  
 
LL-37 production is modulated in many ways. As a response to endoplasmic 
reticulum stress, sphingosine-1-phosphate is produced leading towards 
cathelicidin expression through NF-κB pathway (Park et al., 2011, 2013). The 
vitamin D pathway in the induction of cathelicidin expression is also extensively 
studied as the peptide is important in skin diseases (Liu et al., 2007; Schauber 
and Gallo, 2008). However, ligands that signal cathelicidin expression in 
keratinocytes may not have the same effect in colonocytes (Peric et al., 2009). 
In the intestines, normal microbiota is among the factors responsible for basal 
AMP presence (Verdu et al., 2015). Cathelicidin gene expression was also 
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stimulated by LPS (Wu et al., 2000). Cell differentiation stimulated by short 
chain fatty acids also lead to increased cathelicidin production (Hase et al., 
2002; Schauber et al., 2003). Several bacterial species can induce cathelicidin 
production in the intestines such as Salmonella enterica, invasive E. coli and 
Mycobacerium tuberculosis (Hase et al., 2002; Rivas-Santiago et al., 2008; Wu 
et al., 2000). On the other hand, several bacterial products could downregulate 
cathelicidin expression. For example, cholera toxins from Vibrio have this effect 
on intestinal epithelial cells. 
 
The fact that LL-37 and other AMPs’ expression could be stimulated has led to 
further studies exploring on whether induction of their expression can resolve 
or alleviate known diseases (Agerberth et al., 2013). In Blastocystis infections, 
this could be relevant as the experiments discussed in previous chapters show 
the efficacy of LL-37 in killing the parasite. In this chapter, the gene expression 
modulated by Blastocystis in mouse intestinal explants and human intestinal 
epithelial cells were determined. LL-37 production and secretion inside the cell 
and in culture supernatant were also investigated. 
 
6.2 Materials and Methods 
 
6.2.1 Mouse intestinal explants exposure to Blastocystis  
 
Mouse experiments were done by Dr. Sitara Rao Ajjampur. C57BL/6 mice were 
obtained from NUS and housed in an animal biosafety level 2 facility. Mice (7-
9 wk old) were euthanized by CO2 inhalation. The intestinal tract was dissected 
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out and placed in 50 ml tubes with complete media comprising of Dulbecco's 
modified Eagle's medium (HyClone) supplemented with 10% heat-inactivated 
fetal bovine serum and 1% each of sodium pyruvate and MEM and penicillin-
streptomycin (Gibco) at final concentrations of 2,000 units/mL each of the 
antibiotics. The tissue was then dissected into segments of distal colon, proximal 
colon, caecum and terminal ileum, opened along the mesenteric edge and 
intestinal contents removed. The segments were washed gently in cold 
penicillin-streptomycin and cut into bits measuring 1.5 cm × 1 cm. The explants 
were affixed onto 2% agarose layers in 6 well plates with the serosal surface 
facing down in pre-warmed complete media with penicillin-streptomycin 
(Gibco). Explants were incubated with 5 × 107 live Blastocystis ST7-B parasites 
for 1 h at 37°C. For all assays, more than one litter was used in order to avoid 
any litter-specific effects. After incubation, the explants were frozen in Trizol 
(Invitrogen) at -80ºC till further processing. The animal experiments were 
performed in accordance with the Singapore National Advisory Committee for 
Laboratory Animal Research guidelines. The protocol (R13-5890) was 
reviewed and approved by the NUS Institutional Animal Care and Use 
Committee. 
 
6.2.2 Co-culture of Blastocystis with HT-29 intestinal epithelial cells  
 
HT-29 epithelial cells were used to study whether Blastocystis parasites affect 
the expression of LL-37 in host cells. Cells were maintained in T-75 flasks 
(Corning) in humidified incubator with 5% CO2 at 37ºC. Complete culture 
medium consisted of 10% heat-inactivated fetal bovine serum (Gibco), 1% each 
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sodium pyruvate (Gibco), non-essential amino acids (Gibco) and penicillin-
streptomycin in Dulbecco’s modified Eagle’s medium (DMEM) 
(ThermoScientific). Cells were seeded onto 6-well plates (Greiner) using 
complete medium. After reaching confluency, HT-29 cells were incubated for 
48 h with serum-free media supplemented with 3mM sodium butyrate (Sigma-
Aldrich). HT-29 cells were then co-cultured with Blastocystis cells at 10 MOI 
(multiplicity of infection) for 1 h. Culture supernatant were collected and set 
aside for determination of LL-37 secretion. The viability of HT-29 cells after 
co-culture were determined using trypan-blue exclusion assay. 
 
6.2.3 Quantitative real-time PCR (qRT-PCR)  
 
Induction of cathelicidin-related antimicrobial peptide (CRAMP) gene 
expression on mouse intestinal explants and CAMP gene on HT-29 cells were 
determined after exposure to Blastocystis. Mouse explants in Trizol were 
homogenized with ZrO beads in a tissue homogenizer (WisBioMed) and RNA 
extracted from homogenates using the Trizol method followed by further 
purification with the nucleospin RNA kit (Machery Nagel). HT-29 cells were 
homogenized and lyzed with RNAzol (Molecular Research Center). Total RNA 
was extracted following the manufacturer’s protocol. Synthesis of cDNA was 
done using iScript cDNA synthesis kit (Bio-Rad) with 1µg of RNA sample in 
iCycler (Bio-Rad) thermocycler using the suggested protocol. qRT-PCR was 
then performed using iTaq Universal SYBR Green Supermix kit (Bio-Rad), 1µl 
of cDNA and 500nM each of primers (Sigma-Aldrich): CRAMP-F: 5’-TTT 
TGA CAT CAG CTG TAA CG-3’ and CRAMP-R: 5’-GCT TTT CAC CAA 
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TCT TCT CC-3’ for mouse samples; CAMP-F: 5’-AGT GAA GGA GAC TGT 
ATG TG-3’ and CAMP-R: 5’-ATT TTC TTG AAC CGA AAG GG-3’ for HT-
29 samples.  Mouse beta-actin (mBA-F: 5’-GAT GTA TGA AGG CTT TGG 
TC-3’ and mBA-R: 5’-TGT GCA CTT TTA TTG GTC TC-3’) and human 
glyceraldehyde 3-phosphate dehydrogenase (GAPdH) (hGAPdH-F: 5’-CTT 
TTG CGT CGC CAG-3’ and hGAPdH-R: 5’-TTG ATG GCA ACA ATA TCC 
AC-3’) genes were used as endogenous controls. Gene expression analysis was 
done using iQ5 v2.1 software (Bio-Rad) which uses the 2-ΔΔCt method.  
 
6.2.4 LL-37 secretion assay  
 
To quantitatively determine LL-37 secretion in HT-29 cells, supernatant (100 
µl) from co-culture with Blastocystis were used to coat flat-bottom 96-well 
Maxisorp plates (Nunc) for 18 h at 4ºC. Excess supernatant was disposed and 
LL-37 peptide concentration was determined using an enzyme-linked 
immunosorbent assay (ELISA). The plates were washed 3 times using PBS with 
0.05% Tween-20 (PBS-T) wash buffer and blocked with 1% bovine serum 
albumin (BSA) (Santa Cruz Biotechnology) for 2 h at 25ºC. LL-37 were probed 
with 1:5000 rabbit polyclonal anti-LL37 human IgG antibody (Abcam) in 
blocking solution. After 1 h, the wells were washed 4 times with PBS-T. 1:1000 
goat polyclonal secondary antibody to rabbit IgG HRP-conjugated antibody 
(Abcam) in blocking solution was added and incubated for 25ºC. After 1 h, the 
wells were washed 4 times with PBS-T. The wells were then incubated with 
substrate 2,2'-Azinobis [3-ethylbenzothiazoline-6-sulfonic acid] (ABTS) 
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(Sigma-Aldrich) for 5-10 min. Absorbance was read at 492 nm using Tecan 
Infinite F200 microplate reader. 
 
6.2.5 Fluorescence microscopy  
 
To visualize expression of LL-37 in HT-29 cells, a fluorescence microscopy 
assay was used. HT-29 cells were grown to confluency in 24-well cell culture 
plates (Greiner) with poly-L-lysine treated glass coverslips. The complete 
medium was then replaced with 3mM sodium butyrate in serum-free medium. 
After 48 h, co-cultivation with Blastocystis ST1-NUH9, ST4-WR1 and ST7-B 
at 10 MOI for 1 h was done. HT-29 cells were then washed with PBS and fixed 
with absolute methanol for 15 min at -20ºC. The cells were then washed with 
PBS and blocked with 5% normal goat serum in PBS for 2 h. LL-37 was probed 
using 1:500 rabbit polyclonal anti-LL37 human IgG antibody (Abcam) in 
blocking solution overnight at 4ºC. After washing 3 times for 5 min each with 
PBS-T, incubation was done with 1:1000 goat polyclonal secondary antibody 
to rabbit IgG FITC-conjugated antibody (Abcam) in blocking solution for 1 h 
at 25ºC. The cells were then washed 3 times. The glass coverslips were then 
mounted using Vectashield mounting medium and examined using Olympus 
BX60 fluorescence microscope. Total cell fluorescence was quantified using 









6.3.1 Blastocystis induces cathelicidin expression and secretion 
 
Increase in cathelicidin mRNA was detected in mouse intestinal explants and 
HT-29 human intestinal epithelial cells. Mouse intestinal samples were 
sectioned into terminal ileum, caecum, proximal colon and distal colon sections 
and subsequently inoculated with Blastocystis ST7-B cells. qRT-PCR analysis 
showed that mouse distal colon explants showed a net upregulation of CRAMP 
gene when exposed to the parasite (Fig. 6.1 A). HT-29 cells also showed 
upregulation of cathelicidin gene expression when co-incubated with 
Blastocystis ST1-NUH9, ST4-WR1 and ST7-B isolates (Fig. 6.1 B). ELISA 
results showed an increase in cathelicidin in HT-29 culture supernatant when 
incubated with Blastocystis (Fig. 6.1 C). At equal multiplicity of infection 
(MOI), ST1-NUH9 showed the highest induction, followed by ST7-B and ST4-
WR1 isolates. HT-29 cells 95% viability in all the wells and no significant 
difference in viability was found between cells with parasite and those without 
(Fig. 6.2). Viability of HT-29 cells was checked using Trypan-blue exclusion 
assay to confirm that the peptide present in the supernatant is not due to dying 
cells (Fig. 6.2). Fluorescence microscopy also showed increase in FITC-staining 
of HT-29 cells when incubated with Blastocystis (Fig. 6.3). The specificity of 











Fig. 6.1. Blastocystis induces LL-37 expression in mouse distal colon explants 
and HT-29 colonic epithelial cells. Intestines from five mice were externalized 
and partitioned into terminal ileum (TI), caecum, proximal colon (PC) and distal 
colon (DC) (A). These segments were exposed to Blastocystis ST7-B isolates 
for 1 h. CRAMP gene expression was determined using qRT-PCR. Distal colon 
explants showed significant upregulation of CRAMP gene. Three Blastocystis 
isolates (NUH9, WR1 and B) representing three STs (1, 4 and 7, respectively) 
also induced CAMP gene expression in confluent HT-29 cells after 30 min of 
co-incubation at 10 MOI (B). Supernatant from the co-culture showed 
significant increase in LL-37 content after 1 h of co-incubation as determined 






























Fig. 6.2. Trypan-blue exclusion assay was used to determine viability of HT-29 
cells after co-incubation with Blastocystis. No significant differences were 
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Fig. 6.3. Flow cytometry was used to demonstrate the specificity of anti-LL-37 
antibody used in ELISA, fluorescence microscopy and imaging flow cytometry 
experiments. The graph shows FITC-staining of Blastocystis treated or 
untreated with 10 µg/ml LL-37, with or without the presence of either one of 
the antibodies. Only cells treated with LL-37 and with the two antibodies 





Fig. 6.4. Confluent HT-29 cells in monolayer increase production of 
cathelicidin after incubation with Blastocystis. Immunofluorescence assay 
images showed a basal level of cathelicidin production in differentiated HT-29 
cells (A) but absent in undifferentiated cells (B). Differentiated HT-29 cells 
incubated with Blastocystis ST1-NUH9 (C), ST4-WR1 (D) and ST7-B (E) 
showed brighter fluorescence after 1 h co-incubation at 10 MOI. Negative 






The experiments conducted in this chapter showed that Blastocystis upregulated 
LL-37 expression and secretion in intestinal epithelial cells. This was seen in 
other gastro-intestinal infections of protozoan parasites such as Entamoeba 
(Cobo et al., 2012) and Cryptosporidium (Huang et al., 1990). In the mouse 
model, the Blastocystis ST7-B isolates could induce mouse intestinal cells to 
express CRAMP genes, the homologue of human cathelicidin in mice. 
However, this upregulation was only seen in the distal colon of mice. This is 
relevant since Blastocystis is known to specifically colonize the large intestine 
in humans (Ajjampur and Tan, 2016). In the in vitro model using HT-29 cells, 
all Blastocystis isolates representing 3 STs could upregulate LL-37 gene 
expression, peptide production and secretion inside and outside the cell, 
respectively. The level of expression varied, however, from one isolate to 
another. This possibly contributed to the differences in symptomatology and 
pathogenesis in Blastocystis infections as reported in other studies (Casero et 
al., 2015; Das et al., 2016; Safadi et al., 2013).  
 
That Blastocystis could upregulate LL-37 in intestinal cells was also relevant 
for another reason. The induction of AMPs can be used as indicator of a disease 
state. In a study comparing the concentration of human beta-defensin 2 levels 
in fecal samples from ulcerative colitis and irritable bowel syndrome patients 
and healthy controls, the latter had significantly lower level compared to the 
first two (Langhorst et al., 2007). While this study sought to detect only LL-37, 
it is probable that other AMPs could be upregulated as well. The modulation of 
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AMPs by Blastocystis could therefore contribute to the elucidation of 
pathogenesis of the parasite. LL-37 and other AMPs are elements of the innate 
immunity. Blastocystis induces a slight nitric oxide (NO) production in 
epithelial cells as reported (Mirza et al., 2011a). But this phenomenon is only 
observed in ST4-WR1 isolate. In contrast, ST7-B isolate downregulates NO 
production by inhibiting expression of nitric oxide synthase. In this light, it 
appears that host immune responses during Blastocystis infections are a 
complex array of events which depends on the ST of the parasite.  
 
The concentration of induced LL-37 in the culture supernatant is at nanogram 
level (<100 ng/ml). This is consistent with the estimated concentration of LL-
37 (or β-defensins) at mucosal sites which is less than 2 µg/ml (Lai and Gallo, 
2009). At this concentration, complete lysis of the parasite’s population may not 
occur. However, AMPs are known to act synergistically (Alaiwa et al., 2014; 
Guo et al., 2013; Yu et al., 2016). It is probable that a lower LL-37 concentration 
is needed to control the parasite when the peptide is combined with other AMPs. 
There is also the presence of the mucus layer to consider. This structure 

















7.1 General Discussion 
 
This research study sought to explore the role of AMPs and its effects on 
Blastocystis in the context of host-pathogen interactions. AMPs are diverse 
molecules found across different types of organisms. Some are endogenous to 
the host and fulfill several functions including direct killing of the pathogens. 
AMPs’ binding to targets is not dependent of conformation but by electrostatic 
attraction. The pathogen’s ability to develop resistance factors against them are 
generally non-existent (Ho et al., 2013; Li et al., 2012; Wang, 2014). These 
points make it attractive to use AMPs as antibiotics or at least utilize the AMP’s 
structure as a template to design new drugs (Fjell et al., 2012; Peters et al., 
2010). The importance of AMPs in innate immunity of multicellular organisms 
is now well established. Since the 1980’s many AMPs from different organisms 
have been characterized and tested for a variety of functions especially on their 
antibacterial properties (Zasloff, 2016). Despite these advances, knowledge on 
the roles of AMPs in parasitic infections remains scant. In a list of thirty seven 
well-studied AMPs arranged by date of discovery, only 7 have been found to 
have anti-parasitic activities (Wang, 2014). One reason for this could be that 
very few studies are done to investigate the effect of AMPs on parasites. The 
results in this present study therefore contributes significantly to establishing 
the critical role of specific AMPs in a parasitic infection. In this study, LL-37, 
and endogenous AMP in human colon, was found to be effective in growth 
inhibition of Blastocystis across different STs. LL-37 has been found to kill 
other protozoan parasites (Scott et al., 2002). It had a deleterious effect on E. 
histolytica trophozoites at 10-50 µM concentration (Rico-Mata et al., 2013) 
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although the parasite could produce cysteine proteases that degrade the peptide 
(Cobo et al., 2012). But these kinds of studies are infrequent compared to other 
investigations involving bacteria considering that parasitic infections are still a 
burden in many countries. This study therefore contributes to this dearth of 
information with the inclusion of Blastocystis as a LL-37-susceptible eukaryotic 
parasite. The other set of AMPs tested on Blastocystis are the β-defensins. These 
peptides, in contrast to LL37, showed little or no direct effects on Blastocystis. 
Results in this study however could not completely dismiss the significance of 
these peptides in Blastocystis infections. In physiological setting, these peptides 
may still be significant as additive and synergistic activities of endogenous 
AMPs have been reported (Yu et al., 2016).  
 
LL-37 inhibited the growth of Blastocystis but this effect varied between STs as 
indicated by different IC50 values of the peptide on different Blastocystis isolates 
(Table 2.1). This variation in sensitivity of Blastocystis STs to LL-37 had been 
further investigated looking at membrane permeabilization with brightfield 
microscopy, scanning electron microscopy and flow cytometry. Again, a ST7 
isolate showed that it is less affected by LL-37 compared to isolates from ST1 
and ST4 as shown by flow cytometry with PI-staining. It also took a longer time 
to disrupt the membrane of ST7-B isolate compared to other isolates from 
different STs. LL-37-induced surface disruption correlated with the shape 
change happening in Blastocystis as more cells from ST1 and ST4 populations 
became more irregular in shape compared to ST7 (Fig. 4.9). During these 
investigations, there was an opportunity to resolve unknown status of several 
Blastocystis morphological forms. The imaging flow cytometry results in this 
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study indicated that some of these forms may not have biological or 
reproductive significance at all. For example, amoeboid forms were thought to 
be budding cells undergoing an alternative mode of reproduction (Yamada and 
Yoshikawa, 2012). The findings in this study could not verify this. However, 
the cytometry data indicated that most of these amoeboid cells are dying cells. 
The application of high-content imaging cytometry contributed to a better 
understanding of Blastocystis biology.  
 
Aside from drug or host defense factors sensitivity, the pathogenicity of 
Blastocystis and corresponding host immune responses also need to be 
elucidated. It is known that Blastocystis colonizes the large intestines (Ajjampur 
et al., 2016) but specific events leading to the survival and colonization of the 
parasite still needs to be identified. With regard to innate immune response 
against Blastocystis, only one related study has been published which discussed 
the role of nitric oxide, an element of innate immunity, in Blastocystis infections 
(Mirza et al., 2011a). Results in this present study further added to the cellular 
events that occur when the parasite interacts with intestinal epithelial cells. Co-
culture experiments showed that Blastocystis stimulates additional LL-37 
secretion. However, LL-37 potency varied and can only be applied to ST1 and 
ST4 isolates. This meant that Blastocystis ST7 isolates could be more 
pathogenic by virtue of its ability to evade the first line of host defense including 
AMPs. Several other studies have already pointed the greater pathogenic 
potential of Blastocystis ST7 isolates. A clinical case could also be linked to this 
phenomenon as Blastocystis ST7-B isolate has been isolated from a 
symptomatic patient (Ho et al., 1993). These isolates are more adhesive, capable 
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of compromising the intestinal barrier and impedes nitric oxide production, 
which is not the case compared to isolates from different STs (Mirza et al., 
2011a; Wu et al., 2014). The relative resistance of ST7 isolates against LL-37 
is therefore an additional factor to the pathogenic potential of these isolates. The 
fact that Blastocystis ST7 isolates can withstand the presence of LL-37 (and 
probably other endogenous AMPs) while others could not, further differentiate 
it from other Blastocystis STs. The added value of the findings in this study was 
that several isolates of different STs have been used. This is significant since 
Blastocystis is a species complex and many studies indicate that one observation 
in one isolate may not necessarily be the case in another isolate of another ST 
(Tan, 2008; Teo et al., 2014).  
 
The factors that are responsible for Blastocystis ST7 isolates’ relative resistance 
to LL-37 were investigated. The starting point in this particular study was how 
some species of bacteria evade or negate the effect of AMPs particularly LL-
37. Experiments in the present showed that some of these factors are also 
observed in a Blastocystis ST7 isolate. For example, ST7-B cells produced 
excretory-secretory products that contain proteases. These proteases were then 
able to degrade LL-37. The specificity of these proteases was not investigated 
but it is possible that these could have broad effects on different AMPs secreted 
by the host. Further studies could also focus on whether these proteases are 
induced or these are constitutively secreted by the parasite. Another interesting 
observation was the ability of Blastocystis to produce an acidic environment 
that attenuated LL-37 activity. This occurrence was only observed in a ST7 
isolate. This suggests therefore an innate ability of this particular ST to 
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counteract LL-37 attack. As many AMPs are also sensitive to pH changes, this 
could mean that Blastocystis ST7 elimination could require more potent host 
factors. The presence of a surface coat in Blastocystis has also been studied 
specifically on its role in protecting the parasite from AMPs. The exact 
construction of this outer coat is still unknown. There have been sugar residues 
identified (Lanuza et al., 1996) but their role in the parasite’s survival and 
infectivity had not been determined. In this study, the surface coat has been 
visualized and measured. Fluorescence-antibody tagging of the surface coat 
showed that it did not totally eliminate the affinity of LL-37 to the parasite’s 
membrane. However, it may be possible that it could at least diminish the 
attraction of the peptide since the thickness of the surface coat correlates with 
the degree of saturation of LL-37 binding (Fig. 4.10 and 5.3). Aside from these 
factors, others may be involved as well in protecting the parasite from AMPs 
and other elements of innate immunity. For example, efflux systems present in 
some bacteria (Cole and Nizet, 2016), may also be present in some Blastocystis 
isolates. Sequestration of LL-37 by M1 proteins expressed on the surface of 
bacteria has been observed (LaRock et al., 2015). It would be interesting know 
if these proteins are also expressed in the surface coat of Blastocystis. 
 
All Blastocystis STs used in co-culture with intestinal epithelial cells have been 
able to upregulate LL-37 expression and secretion in the host cells (Fig. 6.1, 6.4 
and 6.5). The stimulation for LL-37 expression was also rapid, occurring within 
30 minutes in terms of gene expression and within an hour in terms of secretion 
outside the cell. This suggests that AMPs in general are one of the immediate 
host responses triggered in the presence of a Blastocystis infection. The amount 
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of LL-37 however was not enough to significantly inhibit Blastocystis (Fig. 6.1 
C). Nevertheless, the physiological concentration of the peptide may be more 
concentrated within the mucus layer. The synergistic effect of AMPs could also 
be considered and perhaps these and other factors may be sufficient to eliminate 
the parasite despite the low levels of induced LL-37 seen in cell culture studies. 
Furthermore, the concentration of the peptide in physiological setting is still 
unknown and would be difficult to estimate. This would probably require more 
sensitive measurements in clinical samples. 
 
The ability of Blastocystis to stimulate LL-37 secretion in the host is a 
significant event not only because it could affect the parasite directly but also 
because it could result into an array of downstream host immune responses. 
While AMPs are elements of innate immunity, their functions go beyond it by 
serving as bridges to adaptive immunity (Scott et al., 2002). LL-37, for example, 
upregulates cytokines which includes interleukin (IL)-17A, IL-8 and interferon 
gamma (IFNɣ) (Vandamme et al., 2012). On the other hand, Blastocystis were 
also observed to stimulate production of cytokines such as IL-8 and 
granulocyte-macrophage colony stimulating factor. It would be interesting to 
know whether these cytokines production is a direct result of the parasite’s 
stimulation or mediated by LL-37. If it is the latter, then AMPs, and LL-37 in 
particular, do have an important role in combatting invasion by being a 





Intestinal unicellular parasites have been reported to cause agitation in normal 
gut microbiota. And perturbation of microbiome results in pathologies (Collins, 
2014; Flint et al., 2012). Cryptosporidium, for example, damages the intestinal 
epithelium which then affects the microbiome populations (Ras et al., 2015). 
Another intestinal protistan parasite, Giardia, has been shown to disrupt 
microbiota biofilms in mice leading to pathophysiology (Beatty et al., 2013). 
Blastocystis has also been found to cause changes in the members in microbiota. 
In a study of patients with IBS, the presence of Blastocystis had a negative 
correlation with the presence of Bifidobacterium sp., which is considered a 
probiotic. Another study reported on the association of the parasite with 
increased diversity of bacterial microbiota in the human gut (Audebert et al., 
2016). This means that Blastocystis could be considered as a factor that 
promotes healthy gut and prevents dysbiosis. Although subtyping was done in 
the previous study, the sample size was small and Blastocystis ST distribution 
did not significantly differ between IBS and control. But whatever the scenario, 
it could be said that Blastocystis impacts the populations of microbiota in the 
human gut and the ramifications of this event could be investigated further along 
with other underlying factors.  
 
In the light of present study, the ability of Blastocystis to modulate AMP could 
also affect microbiota populations in the human gut. AMPs are now known to 
shape the composition of gut normal microbiota (Muniz and Yeretssian, 2012). 
In the two studies mentioned concerning Blastocystis and microbiota, it would 
be interesting to investigate on whether the changes in the bacterial population 
is mediated by LL-37 and other AMPs. AMP expression is tightly regulated and 
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ability of Blastocystis to disrupt this could lead to loss of gut homeostasis.  
Blastocystis then would be indirectly responsible for the changes in the 
microbiome populations mediated by high AMP release in the intestinal lumen. 
The changes in microbiome then could lead colonization of invading pathogens. 
In this study, LL-37 has been the only AMP identified to be upregulated by 
Blastocystsis. In the future, modulation of other AMPs could be investigated as 
well. LL-37 has a potent antibacterial activity (Vandamme et al., 2012) which 
does not distinguish beneficial microbes from harmful ones. The sudden 
increase of LL-37 in the colon could lead to elimination of certain members of 
microbiota which then could cause intestinal disorders. Some AMPs toxic to 
harmful bacteria are not upregulated by invading pathogens but constitutively 
expressed due to the presence of microbiota. For example, the secretion of 
RegIIIɣ, which has antimicrobial activity against Gram positive bacteria, is 
triggered by commensal bacteria (Srikanth et al., 2008). In this scenario, 
Blastocystis would then be indirectly the cause of the disease state even if the 
parasite does not survive for long in the colon by preventing other immune 
factors from being secreted. These possible scenarios could then be investigated 
and contribute in solving questions in the host-pathogen interactions occurring 
in Blastocystis infections. In short the cross-talk between microbiota, host 
epithelial cells and immune effectors including AMPs which are the foundations 
for gut homeostasis (Öhman et al., 2015) could be disrupted by Blastocystis. 
And this study, which determined that Blastocystis can upregulate LL-37 





7.2 Future directions 
 
This study explored the effects of AMPs on Blastocystis. The differences in 
susceptibilities of Blastocystis isolates have been studied further as well as some 
parasitic factors that could be linked to these variations. Further investigations 
could focus on specific secretory products of Blastocystis that could contribute 
to Blastocystis isolates’ resistance against AMPs. For example, secretory 
products of ST7-B have been found to contain proteases that can degrade LL-
37. These proteases can be isolated and characterized in future studies to give a 
clearer picture on the pathogenesis of the parasite. The potential of inhibiting 
these proteases could be relevant in developing drugs against Blastocystis. The 
surface coat of the parasite may also be worth studying. Aside from identifying 
its basic ultrastructure and residue content, functional studies could be done to 
ascertain its role in Blastocystis physiology. This could also be relevant in 
elucidating the parasite’s virulence.  
 
Additional experiments could also be done to provide more value to the findings 
in this study. The effect of low pH in attenuating LL-37 activity is a known 
phenomenon. In addition, the acidic pH caused by Blastocystis ST7-B isolates 
may also lead to the decrease in affinity of cationic AMPs to the parasite’s 
membrane. This can be studied by chemically modifying surface charges in 
Blastocystis. As mentioned before, the use of LL-37 antibodies and inhibitors 
in Blastocystis AMP challenge could also give an idea on the potency of the 




Blastocystis could upregulate AMP expression in host epithelial cells. However, 
this study did not elaborate on how this could occur. Specifically, it could be 
interesting if physical contact between parasite and host cell is necessary to 
trigger expression of AMPs. If secretory products are enough to produce this 
effect, further studies could focus on identifying specific molecules from the 
parasite. This could be significant when therapeutic studies are conducted which 
are centered on increasing the expression of AMPs.  
 
In this study, only three AMPs have been selected since these are secreted by 
epithelial cells. In the future, other AMPs could be investigated. For example, 
α-defensins in the small intestine could play a role in preventing the survival of 
Blastocystis as it passes through the gastrointestinal tract. These are produced 
by specialized cells and therefore, other techniques in co-culture experiments 
are needed. It would also be interesting to study the synergism of AMPs as well 
as the additive effects of the other elements of innate immunity in controlling 
Blastocystis colonization.  
 
The experiments in this study involved Blastocystis and host epithelial cells. 
However, it should be acknowledged that in actual infections, there is also the 
presence of the microbiome in the gut. This element increases the complexity 
of the host-parasite interactions mediated by AMPs. Future studies therefore 
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could involve members of normal microbiota along with the parasite and host 
cells.  
 
In general, findings in this study would be more significant when verified with 
in vivo studies. It may be necessary to use a mouse model which is incapable of 
expressing certain AMPs. Infection studies would then seek to investigate if a 
certain AMP is necessary in controlling and eliminating Blastocystis infection. 
The modulation of AMPs by Blastocystis could also be established in animal 
experiments. The microbiome study mentioned earlier could proceed with the 
availability of appropriate animal models.    
 
7.3 Conclusions  
 
Figure 8.1 provides a summary model encapsulating the major new findings of 
this study in relation to Blastocystis-AMP interactions. 
 
1. Blastocystis is susceptible to growth inhibition by endogenous AMPs. 
LL-37 has a broad activity on all isolates representing Blastocystis ST1, 
4 and 7. hBD-2 only affects ST4 isolates while hBD-1 does not show 




2. LL-37 causes membrane permeabilization in Blastocystis as shown by 
flow cytometry. Scanning electron microscopy also shows breakage of 
the parasite’s surface when treated with the peptide. Imaging flow 
cytometry indicates morphological changes from round cells to 




3. There is a variation in the sensitivity of Blastocystis isolates to LL-37. 
ST7 are relative resistant to the AMP as indicated by higher IC50 values. 
Moreover, a representative isolate (B) from ST7, when treated with LL-
37, has lesser proportion of cells being permeabilized, takes longer time 
to lyse and has lesser morphological changes compared to isolates of 
ST1 and ST4. 
 
4. The mechanisms of resistance of ST7-B isolate to LL-37 has been 
investigated. These include the parasites ability to secrete proteases that 
degrade the peptide. The acidic environment caused by the isolate also 
attenuates LL-37 activity. Lastly, the surface coat of the isolate is thicker 
compared to other STs and may play a role in protecting the cell from 
LL-37 attack. The surface coat of Blastocystis does not entirely prevent 
LL-37 from binding to the cell surface but it may obstruct the peptide 





5. This study also involved the development, optimization and application 
of a new method for studying Blastocystis which shed light on the 
significance of the different morphological forms of the parasite. Several 
observations using this method indicate that majority of the irregularly-
shaped cells (some would label as amoeboid) are dying cells. The 
granular forms also have viable and non-viable population with the latter 
showing a higher mean granularity. The multinucleated cells in 
Blastocystis are rare and cells with more than three nuclei are virtually 
non-existent in ST4 isolates. 
 
6. Lastly, expression studies indicate that Blastocystis upregulates LL-37 
expression and secretion in intestinal epithelial cells. In mouse studies, 
upregulation of CRAMP was seen in the distal colon of mice when 
inoculated with the parasite. Co-culture studies coupled with qPCR, 
confocal microscopy and ELISA also showed higher LL-37 expression 












Fig. 7.1. The interactions between Blastocystis subtypes and LL-37. 
Blastocystis STs induce epithelial cells to secrete LL-37. ST1 and ST4 are 
susceptible to LL-37 attack while ST7 is relatively resistant. An isolate of ST7 
(B isolate) was found to secrete proteinases that degrade LL-37. It could also 
lower the pH that attenuated LL-37 activity. It has a thicker surface coat that 
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Blastocystis Isolate B Exhibits Multiple Modes of Resistance against
Antimicrobial Peptide LL-37
John Anthony Yason, Sitara Swarna Rao Ajjampur, Kevin Shyong Wei Tan
Laboratory of Cellular and Molecular Parasitology, Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore,
Singapore
Blastocystis is one of the most common eukaryotic organisms found in humans andmany types of animals. Several reports have
identified its role in gastrointestinal disorders, although its pathogenicity is yet to be clarified. Blastocystis is transmitted via the
fecal-to-oral route and colonizes the large intestines. Epithelial cells lining the intestine secrete antimicrobial peptides (AMPs),
including beta-defensins and cathelicidin, as a response to infection. This study explores the effects of host colonic antimicrobial
peptides, particularly LL-37, a fragment of cathelicidin, on different Blastocystis subtypes. Blastocystis is composed of several
subtypes that have genetic, metabolic, and biological differences. These subtypes also have various outcomes in terms of drug
treatment and immune response. In this study, Blastocystis isolates from three different subtypes were found to induce intestinal
epithelial cells to secrete LL-37. We also show that among the antimicrobial peptides tested, only LL-37 has broad activity on all
the subtypes. LL-37 causes membrane disruption and causes Blastocystis to change shape. Blastocystis subtype 7 (ST7), however,
showed relative resistance to LL-37. An isolate, ST7 isolate B (ST7-B), from this subtype releases proteases that can degrade the
peptide. It also makes the environment acidic, which causes attenuation of LL-37 activity. The Blastocystis ST7-B isolate was also
observed to have a thicker surface coat, which may protect the parasite from direct killing by LL-37. This study determined the
effects of LL-37 on different Blastocystis isolates and indicates that AMPs have significant roles in Blastocystis infections.
Blastocystis is an intestinal protistan parasite commonly de-tected in humans and many types of animals (1, 2). This or-
ganism is classified under the stramenopiles, although it lacks
chloroplasts or structures for locomotion, which are common fea-
tures ofmanymembers of this group.Blastocystis is widely distrib-
uted throughout the world. Parasitological surveys usually place
Blastocystis as the most common eukaryotic parasite detected (3,
4). This organism has a global distribution and has numerous
animal hosts. There is little host specificity for this organism, and
there are reports indicating the zoonotic potential of Blastocystis
(5). This organism, in its cyst form, is transmitted via the fecal-to-
oral route. It then colonizes the large intestine and is excysted to its
various forms. These forms may appear vacuolar, multivacuolar,
avacuolar, or granular under a light microscope. Blastocystis has
been implicated in a number of intestinal disorders, although its
pathogenesis is yet to be elucidated. There are few reports associ-
ating it with gastrointestinal disease, themost common symptoms
of which are diarrhea, vomiting, nausea, and urticaria (1, 5–7).
Blastocystis is a species complex that is comprised of up to 19
subtypes (STs), with ST1 to ST9 having been isolated from hu-
mans (8). Recently, a report found that ST12 and another possible
novel ST also infect humans (9). Blastocystis STs may differ in size
range, nuclear arrangement, growth rate, and morphology (8).
There have been reports on the differences in host range, protease
activity, and characteristics of the immune response triggered
(10–12). There are also variations in drug sensitivities (13, 14).
Some researchers have suggested that symptomatology is dictated
by ST identity (15).
LL-37 is a 37-amino-acid fragment of human cathelicidin an-
timicrobial peptide (CAMP), which has a direct killing effect on
prokaryotic and fungal organisms (16, 17). Because of its positive
charge, it can bind to negatively charged surfaces, which is a fea-
ture of prokaryoticmembranes (18). It can cause the formation of
pores on the cell membrane and subsequently effect cell lysis.
LL-37 is also amodulator of downstream immune responses such
as the recruitment of other immune cells and the release of cyto-
kines (19). Cathelicidin is produced by epithelial cells, including
those lining the small and large intestines. It is processed by pro-
teases, which results in the LL-37 fragment. There is basal secre-
tion of LL-37 in the intestinal lumen. During infection, LL-37
becomes highly expressed, along with other antimicrobial pep-
tides (AMPs). This leads to other immune responses such as the
recruitment of inflammatory cells and the production of cyto-
kines (20).
In this study, we explore the possible interactions between
Blastocystis and human intestinal AMPs, particularly LL-37. We
determined if the parasite can induce intestinal epithelial cells to
secrete LL-37 using in vitro cell culture and a mouse model. We
also tested several isolates of Blastocystis from three STs for sus-
ceptibility to three colonic AMPs, including LL-37. AMPs had
variable effects on Blastocystis, and their effects on different Blas-
tocystis STs were also not uniform.We identified possible parasite
factors by which Blastocystis can possibly attenuate LL-37 activity.
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Parasite cultivation. Nine previously axenized Blastocystis isolates (21–
23) representing 3 STs (ST1, ST4, and ST7) were used for this study.
Culture medium consisted of 9 ml prereduced Iscove’s modified Dulbec-
co’smedium (IMDM) (Thermo Scientific) supplementedwith 10%horse
serum (Gibco). Culture tubes were maintained inside 2.5-liter sealed an-
aerobic jars with an anaerobic gas pack (Oxoid) at 37°C. Human Blasto-
cystis isolates were acquired from patients at the Singapore General Hos-
pital in the early 1990s, before the Institutional Review Board was
established at the National University of Singapore (NUS). Blastocystis
isolates B, C, E, G, and H are maintained at a microbial collection at the
Department of Microbiology and Immunology of the NUS. NUH2 and
NUH9 were isolated in 2007 from stool samples submitted for routine
heath screening. Permission from the National Healthcare Group Insti-
tutional Review Board was given before project commencement. All sam-
pleswere anonymized.Blastocystis isolatesWR1 and S1were isolated from
a Wistar rat and a Sprague-Dawley rat, respectively.
Subtyping of Blastocystis isolates. The isolates were previously geno-
typed by using primers in a PCR assay based on the organism’s small-
subunit (SSU) rRNA (23, 24) and mitochondrion-like organelle (MLO)
(25) genes. Total DNAs were extracted from 1  106 cells by using a
Qiagen DNA stool kit (Qiagen) according to the manufacturer’s instruc-
tions. PCR was performed by using Q5 High-Fidelity 2 master mix
(New England BioLabs) with 500 ng of DNA sample. All PCR runs were
completed by using a Bio-Rad iQ5 thermocycler. PCR products were se-
quenced and compared to the National Center for Biotechnology Infor-
mation (NCBI) (USA) nucleotide sequence database to confirm subtype
identities.
AMPsusceptibility screening.Todetermine the susceptibility of the 9
Blastocystis isolates to various human intestinal AMPs, a high-throughput
viability assay developed previously by Mirza et al. (14) was applied.
Briefly, flat-bottom 96-well plates (Greiner) were used, with each well
containing 0.5 106 Blastocystis cells. The AMPs human beta-defensin 1
(hBD-1), hBD-2, and LL-37 were dissolved in complete medium at con-
centrations ranging between 0 and 50 M. After 24 h of incubation, res-
azurin dye (Sigma-Aldrich) at a 5% final dilution was added and incu-
bated for another 3 h. Reading of fluorescence was done at 550-nm
excitation and 570-nm emission wavelengths by using a Tecan Infinite
F200 microplate reader. Half-maximal inhibitory concentration (IC50)
values were calculated by using GraphPad Prism software. Synthetic
AMPs at 95% purity were obtained from Singapore Advanced Biologics.
Exposure ofmouse intestinal explants toBlastocystis.C57BL/6mice
were obtained from the NUS and housed in an animal biosafety level 2
clean animal facility. Mice (7 to 9 weeks old) were euthanized by CO2
inhalation. The intestinal tract was dissected and placed into 50-ml tubes
with complete medium comprised of Dulbecco’s modified Eagle’s me-
dium (DMEM) (HyClone) supplementedwith 10%heat-inactivated fetal
bovine serum (FBS) (Gibco), 1% each sodiumpyruvate (Gibco) and non-
essential amino acids (Gibco), and 2,000 U/ml penicillin-streptomycin
(Gibco). The tissue was then dissected into segments of distal colon, prox-
imal colon, cecum, and terminal ileum and opened along the mesenteric
edge, and intestinal contents were removed. The segments were washed
gently in cold penicillin-streptomycin and cut into bits measuring 1.5 cm
by 1 cm. The explants were affixed onto 2% agarose layers in 6-well plates
with the serosal surface facing down in prewarmed complete medium
with penicillin-streptomycin (Gibco). Explants were incubated with 5
107 live Blastocystis ST7 isolate B (ST7-B) parasites for 1 h at 37°C. For all
assays, more than one litter was used in order to avoid any litter-specific
effects. After incubation, the explants were frozen in TRIzol (Invitrogen)
at 80°C until further processing. The animal experiments were per-
formed in accordance with Singapore National Advisory Committee for
Laboratory Animal Research guidelines. The protocol (R13-5890) was
reviewed and approved by the NUS Institutional Animal Care and Use
Committee.
Coculture of Blastocystis with HT-29 intestinal epithelial cells.
HT-29 epithelial cells were used to study whether Blastocystis parasites
affect the expression of LL-37 in host cells. Cells were maintained in T-75
flasks (Corning) in a humidified incubator with 5% CO2 at 37°C. Com-
plete culture medium consisted of 10% heat-inactivated FBS (Gibco) and
1%each sodiumpyruvate (Gibco), nonessential amino acids (Gibco), and
penicillin-streptomycin inDMEM (Thermo Scientific). Cells were seeded
onto 6-well plates (Greiner) by using complete medium. After reaching
confluence, HT-29 cells were incubated for 48 h with serum-freemedium
supplemented with 3 mM sodium butyrate (Sigma-Aldrich). HT-29 cells
were then cocultured with Blastocystis isolates NUH9 (ST1-NUH9),WR1
(ST4-WR1), and ST7-B at anMOI (multiplicity of infection) of 10 for 1 h.
Culture supernatants were collected and set aside for determination of
LL-37 secretion. The viability of HT-29 cells after coculture was deter-
mined by using a trypan blue exclusion assay.
Quantitative real-time PCR. Induction of cathelicidin-related anti-
microbial peptide (CRAMP) gene expression on mouse intestinal ex-
plants and CAMP gene expression on HT-29 cells was determined after
exposure to Blastocystis. Mouse explants in TRIzol were homogenized
with zirconium oxide beads in a tissue homogenizer (WisBioMed), and
RNA was extracted from homogenates by using the TRIzol method, fol-
lowed by further purification with the NucleoSpin RNA kit (Macherey-
Nagel).HT-29 cells were homogenized and lysedwithRNAzol (Molecular
Research Center). Total RNAwas extracted according to themanufactur-
er’s protocol. Synthesis of cDNA was done by using an iScript cDNA
synthesis kit (Bio-Rad) with 1g of RNA sample in an iCycler thermocy-
cler (Bio-Rad) according to the suggested protocol. Quantitative real-
time PCR (qRT-PCR) was then performed by using an iTaq Universal
SYBRgreen Supermix kit (Bio-Rad), 1l of cDNA, and 500 nM(each) the
following primers (Sigma-Aldrich): CRAMP-F (5=-TTT TGA CAT CAG
CTG TAA CG-3=) and CRAMP-R (5=-GCT TTT CAC CAA TCT TCT
CC-3=) for mouse samples and CAMP-F (5=-AGT GAA GGA GAC TGT
ATG TG-3=) and CAMP-R (5=-ATT TTC TTG AAC CGA AAG GG-3=)
for HT-29 samples. Mouse beta-actin (mBA-F [5=-GAT GTA TGA AGG
CTT TGG TC-3=] and mBA-R [5=-TGT GCA CTT TTA TTG GTC TC-
3=]) and human glyceraldehyde-3-phosphate dehydrogenase (GAPDH)
(hGAPdH-F [5=-CTT TTGCGTCGCCAG-3=] and hGAPdH-R [5=-TTG
ATG GCA ACA ATA TCC AC-3=]) genes were used as endogenous con-
trols. Gene expression analysis was done by using iQ5 v2.1 software (Bio-
Rad), which uses the 2Ct method.
LL-37 secretion assay.To quantitatively determine LL-37 secretion in
HT-29 cells, supernatants (100 l) from cocultures with Blastocystis were
used to coat flat-bottom 96-well MaxiSorp plates (Nunc) for 18 h at 4°C.
The excess supernatant was disposed of, and the LL-37 peptide concen-
tration was determined by using an enzyme-linked immunosorbent assay
(ELISA). The plates were washed 3 times by using wash buffer containing
1 phosphate-buffered saline (PBS) with 0.05% Tween 20 (PBS-T) and
blocked with 1% bovine serum albumin (BSA) (Santa Cruz Biotechnol-
ogy) for 2 h at 25°C. LL-37 was probed with a 1:5,000 dilution of rabbit
polyclonal anti-LL-37 human IgG antibody (Abcam) in blocking solu-
tion. After 1 h, the wells were washed 4 times with PBS-T. A 1:1,000
dilution of goat polyclonal secondary antibody to rabbit IgG horseradish
peroxidase (HRP)-conjugated antibody (Abcam) in blocking solution
was added, and the mixture was incubated at 25°C. After 1 h, the wells
were washed 4 times with PBS-T. The wells were then incubated with the
substrate 2,2=-azinobis(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS)
(Sigma-Aldrich) for 5 to 10 min. The absorbance was read at 492 nm by
using a Tecan Infinite F200 microplate reader.
Fluorescence microscopy. To visualize the expression of LL-37 in
HT-29 cells, a fluorescence microscopy assay was used. HT-29 cells were
grown to confluence in 24-well cell culture plates (Greiner) with poly-L-
lysine-treated glass coverslips. Complete medium was then replaced with
3 mM sodium butyrate in serum-free medium. After 48 h, cocultivation
with Blastocystis isolates ST1-NUH9, ST4-WR1, and ST7-B at an MOI of
10 for 1 hwas done.HT-29 cells were thenwashedwith PBS andfixedwith
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absolute methanol for 15 min at20°C. The cells were then washed with
PBS and blocked with 5% normal goat serum in PBS for 2 h. LL-37 was
probed by using a 1:500 dilution of rabbit polyclonal anti-LL-37 human
IgG antibody (Abcam) in blocking solution overnight at 4°C. After the
cells were washed 3 times with PBS-T for 5min each, incubationwas done
with a 1:1,000 dilution of goat polyclonal secondary antibody to rabbit
IgG fluorescein isothiocyanate (FITC)-conjugated antibody (Abcam) in
blocking solution for 1 h at 25°C. The cells were then washed 3 times. The
glass coverslips were then mounted by using Vectashield mounting me-
dium and examined by using anOlympus BX60 fluorescencemicroscope.
Total cell fluorescence was quantified by using ImageJ software version
1.48 (NIH).
Viability staining and flow cytometry. Propidium iodide (PI) (Bio-
Vision) was used to stain Blastocystis cells to assess viability after LL-37
treatment. Blastocystis isolates ST1-NUH9, ST4-WR1, and ST7-B (1 
107 cells/ml) were treated with LL-37 at concentrations of 0, 10, and 100
g/ml for 1 h. A necrotic control was added as a positive control. This was
achieved by heating the cells at 95°C for 15 min. PI was then added to the
cell suspension according to the manufacturer’s instructions. Cells were
then analyzed by using an LSRFortessa instrument (BDBiosciences).Data
analysis was done by using Summit software version 4.3 (Dako).
Scanning electron microscopy. The effects of the LL-37 peptide on
the Blastocystis membrane and surface coat were visualized by using a
scanning electron microscope. Blastocystis cells with and without LL-37
treatment were fixed overnight with 4% glutaraldehyde in PBS. The cells
were then washed and attached to 0.1% poly-L-lysine-treated coverslips
for 30 min. The cells were dehydrated with increasing concentrations of
ethanol. The coverslipswith attached cells were placed into a critical-point
dryer (CPD 030; Balzers) for carbon dioxide infiltration. After drying, the
coverslips were coated with 5- to 10-nm gold particles with a sputter
coater. The cells were visualized with a JEOL JSM-6701F scanning elec-
tron microscope.
Imaging flow cytometry. Morphological changes of Blastocystis cells
caused by LL-37 were observed by using an imaging flow cytometer. Blas-
tocystis cultures were harvested and washed twice with PBS. Cell suspen-
sions with 1  107 cells/ml were stained with 1 g/ml PI (BioVision), 5
M carboxyfluorescein succinimidyl ester (CFSE) (Life Technologies),
and 1 g/ml Hoechst 33342 (Life Technologies) for 15 min. The stained
cells were analyzed by using an Amnis ImageStream MkII imaging flow
cytometer (Merck Millipore) with a 4-laser attachment (375, 488, 561,
and 642 nm). At least 2,000 events per runwere acquired at low flow speed
and a 60 magnification. The gating strategy included selection for
focused cells and then single cells. Histograms based on circularity
indices were generated. Data analysis was done by using IDEAS soft-
ware version 6.1.
LL-37 bound to the surfaces of Blastocystis cells was also visualized by
using imaging flow cytometry. Before the samples were run, 1 107 cells
were treatedwith 50g/ml LL-37 at room temperature. PIwas added, and
the cells were fixed by using 4% formaldehyde for 30 min. The cells were
washed twice and suspended in PBS. LL-37 bound to the Blastocystis cell
surface was probedwith a 1:1,000 dilution of rabbit polyclonal anti-LL-37
human IgG antibody (Abcam) for 30 min. Goat polyclonal secondary
antibody to rabbit IgG FITC-conjugated antibody (Abcam) at a 1:500
concentration was then added, and themixture was incubated for 30min.
All the reactions were done at 25°C.
LL-37 degradation and viability assays. Blastocystis ST7-B and ST4-
WR1 excretory-secretory products (ESPs) were harvested from cultures
grown for 24 h. The cultures werewashed twice in serum-free IMDM.The
cells were then incubated for 2 h in prereduced IMDM at 37°C under
anaerobic conditions at 1 108 cells per ml of IMDM. Culture superna-
tants were then collected by centrifugation at 1,000  g for 10 min and
filtered twice by using 0.2-m-pore-size filters (Millipore). Blastocystis
secreted products were stored at80°C until use. The effect ofBlastocystis
ESPs on peptide integrity was quantitatively determined by an enzyme-
linked immunosorbent assay (ELISA). Briefly, each well of flat-bottom
96-well Nunc MaxiSorp plates was coated with 50 l of LL-37 at a con-
centration of 2 g/ml for 18 h at 4°C. Plates coated with LL-37 were
exposed for 2 h toBlastocystis ESPs alone or ESPs previously incubated for
6 h with 1Halt protease inhibitor cocktail (Bio-Rad) at 37°C. The wells
were then washed with PBS, and the concentration of intact LL-37 was
determined by using an ELISA as outlined above. LL-37 peptide solutions
previously incubated with Blastocystis ESPs were also used for the treat-
ment of Blastocystis cultures. Viability was determined by using flow cy-
tometry and PI staining after treatment. Denatured ESPswere also used in
this assay, which entailed heating of the ESPs for 15 min at 95°C.
Transmission electron microscopy (TEM). Cultures of Blastocystis
cells (1  107 cells) grown for 24 h were harvested, washed, and treated
with 100 g/ml cationized ferritin (Sigma-Aldrich) for 2 h. Cationized
ferritin binds to negatively charged surfaces (26). We found that it was
useful to visualize the surface coat of Blastocystis by providing better con-
trast and maintaining its integrity during the preparation of cells for elec-
tron microscopy. The cells were then fixed overnight at 4°C with 8%
glutaraldehyde. The cells were then washed 3 times with PBS. Postfixation
included incubation of cells with 1%osmium tetroxide and 1%potassium
ferrocyanide in PBS for 2 h. The cells were then washed 3 times. The cells
were dehydrated with absolute ethanol 5 times. Embedding was done for
48 h by using London resin white. The solidified blocks were sectioned,
mounted, and viewed by using a transmission electronmicroscope (JEM-
1010; JEOL).
Statistical analysis. Tests for significant differences were done by us-
ing analysis of variance (ANOVA) and Student’s t test. Error bars repre-
sent standard errors from at least 3 independent experiments. Calcula-
tions and generation of graphs were done with GraphPad Prism 5.0.
RESULTS
Blastocystis STs are inhibited by LL-37.Nine Blastocystis isolates
representing 3 STswere tested for susceptibility to AMP treatment
(Table 1). All isolates from the three subtypes were considered
susceptible to LL-37, although ST7 isolates showed higher IC50s.
Only ST4 isolates were susceptible to hBD-2, while treatment of all
isolates with hBD-1 did not cause a loss of Blastocystis viability.
Blastocystis induces cathelicidin expression inmouse intestinal
explants and human intestinal epithelial cells. Mouse intestinal
samples were sectioned into terminal ileum, cecum, proximal co-
lon, and distal colon sections and subsequently inoculated with
Blastocystis ST7-B cells. qRT-PCR analysis showed thatmouse dis-
tal colon explants showed a net upregulation of the CRAMP gene
when exposed to the parasite (Fig. 1A).HT-29 cells also showed an
upregulation of cathelicidin gene expression when coincubated
with the Blastocystis ST1-NUH9, ST4-WR1, and ST7-B isolates
(Fig. 1B). ELISA results showed an increase in the cathelicidin




ST1 NUH2 50 50 6.0
NUH9 50 50 4.7
ST4 WR1 50 11.4 3.2
S1 50 5.0 5.4
ST7 B 50 50 42.6
C 50 50 23.4
E 50 50 23.2
G 50 50 27.7
H 50 50 28.7
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concentration in the HT-29 culture supernatant when incubated
withBlastocystis (Fig. 1C). At equalMOIs, ST1-NUH9 showed the
highest level of induction, followed by the ST7-B and ST4-WR1
isolates. HT-29 cells showed 95% viability in all the wells, and no
significant difference in viability was found between cells with
parasites and those without (see Fig. S1 in the supplemental ma-
terial). Fluorescence microscopy also showed an increase in FITC
staining of HT-29 cells incubated with Blastocystis (Fig. 2).
LL-37 disrupts the Blastocystis cell membrane. Three isolates
(ST1-NUH9, ST4-WR1, and ST7-B), each representing a partic-
ular subtype, were incubated with 0, 10, and 100 g/ml LL-37 for
1 h, and membrane disruption was analyzed by staining with PI.
The proportion of cells with PI staining was determined by flow
cytometry. All three isolates showed increases in the proportions
of permeabilized cells as the concentration of LL-37 increased. At
100g/ml LL-37,50%of ST1-NUH9 and ST4-WR1 cells had PI
staining, while only 36%of ST7-B cells showedPI staining (Fig. 3).
Time-lapse micrographs show that by as early as 5 min of incuba-
tion of the Blastocystis ST7-B isolate with the peptide, smaller cells
were already undergoing lysis. Larger cells were observed being
lysed after 20 min. Before complete lysis, vesicles were seen form-
ing in a few sections of the cell membrane (Fig. 4A). The cells
appeared to flatten as well. In addition, the membrane-disruptive
effect of LL-37 on a “resistant” isolate (ST7-B) was slower than
that on a “sensitive” isolate (ST4-WR1). Flow cytometry analysis
showed that30% of ST4-WR1 cells had PI staining after 15 min
of treatment with LL-37, while it took 30 min of treatment for
ST7-B cells to reach this proportion (Fig. 4B).
LL-37 causes morphological changes in Blastocystis. An imag-
ing flow cytometer was used to analyze the effect of LL-37 on the
morphology of parasites (Fig. 5A). On average, Blastocystis cells
appear round, with the cytoplasm being pushed to the edge by a
large central vacuole. Irregularly shaped cells in culture are an
indication of poor viability. All three of the isolates studied
showed a decrease in the proportion of round cells when LL-37
was added to the cultures. At 10 g/ml LL-37, the change in the
percentage of round cells was minimal. At 100 g/ml LL-37, the
proportion of round cells is lower by at least half than for un-
treated cultures in all the ST populations (Fig. 5B). Scanning elec-
tronmicroscopy analysis showed the possible phenotypic features
of affected Blastocystis cells. LL-37-treated cells exhibited mem-
brane pores and compressed cells, which may be due to cytoplas-
mic leakage. ST4-WR1 cells also showed fragmentation when
treated with LL-37 (Fig. 5C).
Blastocystis ST7-B, but not ST4-WR1, secretes proteases that
can degrade LL-37. A modified ELISA was used to determine if
Blastocystis ESPs can degrade LL-37. We used ESPs from ST7-B
and ST4-WR1 cultures to represent LL-37-resistant and LL-37-
susceptible isolates, respectively. The absorbance of wells after in-
cubation with ESPs of the ST7-B isolate was lower than that of
wells after incubation with ESPs of ST4-WR1 (Fig. 6A). This indi-
cates that ST7-B isolates produce proteases that can degrade LL-
37. This degradation was inhibited when ESPs were incubated
with a protease cocktail inhibitor prior to the degradation assay. In
addition, PI staining was also used to determine the viability of
Blastocystis cells after treatment with LL-37 previously incubated
FIG 1 Blastocystis induces LL-37 expression inmouse distal colon explants andHT-29 colonic epithelial cells. (A) Intestines fromfivemicewere externalized and
partitioned into terminal ileum (TI), cecum, proximal colon (PC), anddistal colon (DC). These segmentswere exposed toBlastocystis ST7-B cells for 1 h.CRAMP
gene expression was determined by using qRT-PCR. Distal colon explants show significant upregulation of the CRAMP gene. (B) Three Blastocystis isolates
(NUH9, WR1, and B) representing three STs (ST1, -4, and -7, respectively) also induced CAMP gene expression in confluent HT-29 cells after 30 min of
coincubation at anMOI of 10. (C) The supernatant from the coculture shows a significant increase in the LL-37 content after 1 h of coincubation, as determined
by an ELISA. *, P 0.05; **, P 0.001; ***, P 0.0001.
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FIG 2 Confluent HT-29 cells in monolayers increase the production of cathelicidin after incubation with Blastocystis. (A and B) Immunofluorescence assay
images showabasal level of cathelicidin production in differentiatedHT-29 cells (A), whichwas absent in undifferentiated cells (B). (B to E)DifferentiatedHT-29
cells incubatedwithBlastocystis ST1-NUH9 (C), ST4-WR1 (D), and ST7-B (E) show brighter fluorescence after 1 h of coincubation at anMOI of 10. (F)Negative
control. (G) Total fluorescence units were quantified by using ImageJ software. RFU, relative fluorescence units. ***, P 0.0001.
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with the ST7-B ESPs (Fig. 6B). The secreted proteases in the ST7-B
ESPs inactivated LL-37 activity onBlastocystis cells. This, however,
was reversed when ESPs were previously heat denatured before
incubation with LL-37.
The Blastocystis ST7-B isolate decreases the pH in culture and
attenuates LL-37 activity. The pH of complete medium for Blas-
tocystiswas adjusted and used to determine if it has an effect on the
activity of LL-37 on Blastocystis. At pH 6.6, LL-37 had a minimal
effect on the Blastocystis ST7-B and ST4-WR1 isolates, with cell
counts at 90% and 88%, respectively, compared to that with un-
treated cultures. At pH 7.1, the relative resistance of ST7-B was
observed and compared to that of ST4-WR1. Cell counts at this
pH with LL-37 were 76% and 41% for the ST7-B and ST4-WR1
isolates, respectively, compared to untreated cultures. At pH 8.0,
ST7-B and ST4-WR1 cell counts were 44% and 38%, respectively,
of those of untreated cultures. At this pH, the highest level of
activity of LL-37 was observed, which negated the relative resis-
tance of the ST7-B isolate (Fig. 7A).We also determined the pH of
Blastocystis culture medium after 24 h. The average pH of the
Blastocystis ST7-B culture was 6.8, while that of the ST-WR1 cul-
ture was 7.0 (Fig. 7B).
The Blastocystis ST7-B isolate has a thick surface coat com-
pared to that of ST4-WR1. India ink was used as negative stain to
visualize the surface coat of Blastocystis cells. Most cells from
FIG 3 LL-37 causes disruption of theBlastocystis cellmembrane. PI staining and flow cytometrywere used to detect cells with permeabilizedmembranes. Graphs
show proportions of PI-stained cells in ST1-NUH9, ST4-WR1, and ST7-B populations after incubation with 0, 10, and 100 g/ml LL-37 for 1 h. Necrotic
conditions were used as a positive control for PI staining. This was attained by heating Blastocystis cells for 15min at 80°C. There is an increase in the proportion
of permeabilized Blastocystis cells at higher concentrations of LL-37. The ST-B isolate showed relative resistance to LL-37 compared to both the ST1-NUH9 and
ST4-WR1 isolates. **, P 0.001.
FIG 4 (A) Time lapse images of Blastocystis ST7-B cells treated with 100g/ml LL-37 (top) and controls (bottom). Images were taken every 5min. Arrows point
to cells undergoing lysis. Cells are lysed as early as 5 min after the addition of LL-37 (white arrow). (B) Time course lysis experiments using PI staining and flow
cytometry were also done. Graphs show that the membrane-disrupting effect of LL-37 is faster among ST4-WR1 than among ST7-B cells.
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FIG 5 LL-37 causes morphological changes in Blastocystis isolates. Blastocystis cells were incubated with LL-37 for 1 h and analyzed by using an imaging flow
cytometer. (A) Images show round and irregular cells, as determined by the circularity index generated by the software. (B) Bar graphs show that treatment of
Blastocystis STs with LL-37 decreases the proportion of round cells. (C) Scanning electron micrographs also show that these cells have irregular shapes when
treated with LL-37. The white arrows point to possible large membrane pores that could lead to cytoplasmic leakage. LL-37-treated Blastocystis ST4-WR1 cells
also became highly fragmented. *, P 0.05; **, P 0.001.
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ST7-B cultures showed thicker surface coats (Fig. 8A and B). To
observe the surface closely, we used transmission electronmicros-
copy (TEM). Cationized ferritin was used to label negatively
charged elements on the cell surface. Again, TEMshowed a thicker
surface coat for ST7-B cells than for ST4-WR1 cells (Fig. 8C to F).
The coat’s thickness in ST7-B cells was almost three times that of
the coats in ST4-WR1 cells (Fig. 8G). Furthermore, ST7-B surface
coats also appeared to be denser.
LL-37 bindsmore to Blastocystis ST4-WR1 cell surfaces than to
ST7-B cell surfaces. Flow cytometry imaging was used to visualize
LL-37 bound to Blastocystis cells (Fig. 9A). The proportion of cells
with bound LL-37 was higher for ST4-WR1 than for ST7-B (Fig.
9B). Gating out for those cells with bound LL-37, we found that a
high percentage of ST7-B cells was viable compared to the per-
centage of viable ST4-WR1 cells (Fig. 9C). The specificity of the
primary antibody used was demonstrated by using LL-37-treated
and untreated Blastocystis cells with or without the primary or
secondary antibody.
DISCUSSION
Blastocystis causes large-bowel infections among humans, where it
may cause diarrhea, abdominal pain, nausea, and other related
symptoms. The organism is transmitted by the fecal-oral route by
the means of the cyst form. Upon reaching the large intestine, it
transforms into its various vegetative forms. Pathogenic events
include epithelial barrier disruption, adhesion, modulation, and
evasion of host immune responses (5). Since most infections are
self-limiting, it may be presumed that in these cases, Blastocystis is
eradicated before it can colonize and penetrate the intestinal bar-
rier. Events surrounding the removal of this parasite need to be
elucidated. AMPs may be involved in these events, and therefore
their possible roles in limiting Blastocystis-related pathologies
need to be determined.
Host AMPs are important elements of innate immunity. AMP
activities includemembrane pore formation, whichmay cause cell
death directly or allow other molecules to pass through the mem-
brane and bind to intracellular targets (27). Some of these mole-
cules are expressed by epithelial cells and provide an initial defense
against invading pathogens. In this study, we explored the role of
these peptides in humanBlastocystis infections.We focused on the
activity of LL-37 onBlastocystis after determining that this peptide
has broad activity against all the Blastocystis STs that we tested
using a screening assay (Table 1). There have been numerous
studies showing the effectiveness of AMPs against bacterial, fun-
gal, and even viral pathogens. There are, however, few studies on
the action of AMPs on protistan parasites. A review (17) on the
effect of AMPs on two parasites that cause the tropical diseases
leishmaniasis and malaria outlined both positive and negative as-
pects of the use of AMPs against protists. Studies have shown that
AMPs can also disrupt cellular processes in parasites (17). This
makes AMPs promising candidates for drug development. Re-
garding the use of AMPs in human Blastocystis infections, one
study found that analogs of an anuran skin peptide called
magainin were effective against Blastocystis hominis,Trypanosoma
cruzi, and Entamoeba histolytica (28). This 2-decade-old study
showed that theseAMPs can disrupt the cellmembrane, leading to
leakage of cell contents and, eventually, death.
Blastocystis is an enteric parasite, and it is expected to stimulate
host epithelial cells to mount immune responses. For example,
Blastocystiswas found to induce nitric oxide production in epithe-
lial cells as part of the host defense (14). In addition, Blastocystis
could also induce epithelial cells to express antimicrobial peptides
as part of the host’s innate immune response. This is seen in other
gastrointestinal infections by protistan parasites such as Entam-
oeba (29) and Cryptosporidium (30). In this study, we have also
FIG 6 (A) Blastocystis isolate ST7-B (but not ST4-WR1) excreted-secreted products (ESPs) degrade LL-37, as shown by ELISA results. ELISA plates were coated
with the LL-37 peptide, and the plates were incubated with Blastocystis ESPs for 2 h. Degradationwas prevented when ST7-B ESPs were incubated with a protease
inhibitor cocktail prior to incubation with the peptide. OD405, optical density at 405 nm. (B) Viability experiments were also done by using LL-37 previously
incubated with ST7-B ESPs. The graph shows that ST7-B ESPs attenuated LL-37 activity. This was reversed when the ESP was first heated to denature proteins.
*, P 0.05.
FIG 7 pH affects the activity of LL-37 on Blastocystis. (A) At acidic pH, LL-37
does not inhibit Blastocystis, while at neutral and alkaline pHs, both ST4-WR1
and ST7-B are inhibited by the AMP. (B) Blastocystis ST7-B (but not ST4-
WR1) cultures cause the medium to be acidic after 24 h. *, P 0.05.
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FIG 8 Blastocystis ST7-B cells (A, C, and E) have thicker and denser surface coats (arrows) than do ST4-WR1 cells (B, D, and F), as shown by using India ink as
a negative stain for brightmicroscopy (A andB) and transmission electronmicroscopy (C,D, E, and F). (G) Images fromTEMwere used tomeasure the thickness
of the surface coat. The surface coat of the ST7-B isolate is more than double the thickness of that of the ST4-WR1 isolate. *, P 0.05.
Yason et al.
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found that all 3 represented Blastocystis STs are capable of induc-
ing the expression and secretion of LL-37 by intestinal epithelial
cells (Fig. 1B and C and Fig. 2). Blastocystis ST7-B was also able to
induce LL-37 gene expression inmouse distal colon explants (Fig.
1A). This could indicate that LL-37 plays a role when Blastocystis
tries to colonize the intestine. It is possible that LL-37 is among the
first host defense peptides that are secreted in order to prevent
parasite colonization and invasion. Furthermore, the differences
in the abilities of the STs to induce the expression of LL-37 could
also be relevant. Blastocystis ST1-NUH9 is relatively sensitive to
LL-37 and was found to induce the highest level of secretion of
LL-37 in HT-29 cells. This suggests that the pathogenic potential
of ST1-NUH9 would be weaker than that of the ST7-B isolate.
As with AMP studies done on other protistan parasites, Blas-
tocystis is likely to be susceptible to the direct killing effect of
AMPs. As mentioned above, Blastocystis is composed of many
subtypes showing various biological properties, and it is probable
that a few STs will be resistant. Not all AMPs, however, may be
effective against Blastocystis, although its mechanism of resistance
may be different from that of prokaryotic organisms. For example,
themembrane surface of Blastocystis, a eukaryotic organism, has a
structure different from that of prokaryotes, and elements of this
parasite’s membrane may shield the negative charges. This differ-
ence may a factor in the relative resistance of the parasite to anti-
microbial peptide treatment. Some bacteria produce proteases
that can inactivate AMPs (31–33). This may also be the case in
Blastocystis.
In this study, resazurin-based viability assays showed that
among the intestinal AMPs, only hBD-2 and LL-37 can inhibit
Blastocystis. The effectiveness of hBD-2, however, is limited only
to ST4. hBD-1 is constitutively expressed in colonic epithelial
cells. It was found to kill a number of bacterial species, whether
Gram negative or Gram positive (34). We did not find any inhi-
bition when this peptide was added to Blastocystis cultures. hBD-1
and hBD-2 share very similar structures. A difference is found
only on the tri-/disulfidemotifs (35). Bothmotifs have been found
to kill Staphylococcus aureus and Escherichia coli. It is interesting to
note, therefore, that only hBD-2 can inhibit Blastocystis.
On the other hand, LL-37 has been found to be effective against
all Blastocystis STs. Cathelicidins are characterized by a conserved
N-terminal domain that is proteolytically cleaved to generate the
mature, active peptide contained within the C terminus (36).
Thesemolecules are expressed in various immune cells, in salivary
glands, and in epithelia of respiratory, digestive, and reproductive
tracts, while keratinocytes and intestinal cells can be induced to
enhance expression. Its main effect is pore formation in bacterial
FIG 9 LL-37 binds to the cell surface of Blastocystis. (A) Images from the bright-field, FITC, and PI channels are displayed, showing both viable and nonviable
cells with bound LL-37. LL-37 was detected by using FITC-conjugated antibodies. Viability was determined by using PI staining. (B) Blastocystis ST4-WR1 had
a higher proportion of cells with bound LL-37 peptide. (C) Among the cells with bound LL-37, Blastocystis ST4-WR1 had a lower level of viability. *, P 0.05.
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membranes. It was also found to be capable of modulating toxic
effects due to bacterial infection (37). LL-37’s other activities in-
clude a chemotactic effect on blood cells, activation of histamine
release from mast cells, or induction of angiogenesis (38). The
absence of LL-37 has been associated with chronic periodontal
disease (36). The only cathelicidin identified in humans is termed
LL-37, indicating the 37-amino-acid sequence. It has been found
to inhibit a number of Gram-positive, Gram-negative, andGram-
indeterminate bacterial species (39). It has also been found to
cause membrane disruption with vacuolar enlargement in Can-
dida albicanswithin 5min (40).We have found the same effect on
all representative isolates of Blastocystis ST1, ST4, and ST7. LL-37
causes a decrease in viability (Table 1) and membrane permeabi-
lization, as observed by using PI staining (Fig. 5). We also ob-
served the rapidity of LL-37 action. Blastocystis cells were lysed
within 5 min of treatment with LL-37 (Fig. 4). The change in the
morphology of cells from round to irregular was also observed by
using imaging flow cytometry as well as scanning electronmicros-
copy (Fig. 5). Our previous observation has been that irregularly
shaped Blastocystis cells are an indication of poor health (41). LL-
37, as it causes pore formation, may be responsible for the shape
change in Blastocystis cells.
However, as determined by viability assays, the effects of LL-37
are not similar for all the isolates tested, as ST7 isolates have higher
IC50s (Table 1). PI staining (Fig. 3) and observed morphological
changes (Fig. 5) also confirm this finding. The various effects of
LL-37 on different Blastocystis STs suggest that its effectiveness is
subtype dependent. Blastocystis ST7 isolates showed relative resis-
tance compared to ST4 and ST1 isolates. We therefore attempted
to identify the factors in Blastocystis ST7 isolates that may be re-
sponsible for their relative resistance to LL-37.
Blastocystis is known to release proteases (42, 43). Some of
these proteases have been found to directly protect the parasite,
such as those that can degrade antibodies (43). In this study, we
have observed that the excretory-secretory products ofBlastocystis
contain proteases that can degrade LL-37. This effect was seen
only in an ST7 isolate. In a sensitive strain such as ST4-WR1, this
findingwas not observed (Fig. 6). A study on the effect of LL-37 on
an intestinal parasite, Entamoeba histolytica, also revealed the
same outcome (29). The resistance of E. histolytica to LL-37 was
partly due to its ability to release cysteine proteases that could
degrade LL-37.
The attenuation of LL-37 by pH has been reported in previous
bacterial studies. An acidic pHdecreased the ability of LL-37 to kill
Staphylococcus aureus and Pseudomonas aeruginosa (44). That
study found that decreasing the pH from 8.0 to 6.8 can attenuate
LL-37 activity. In this study, we also observed that at pH 6.5, both
Blastocystis ST4-WR1 and ST7-B were not affected by LL-37.
However, at alkaline pH (pH 8.0), both isolates became suscepti-
ble to LL-37 killing (Fig. 7A). Furthermore, we have determined
that the Blastocystis ST7-B isolate is able to cause a change in the
pH after 24 h.We have observed that the pH adjustment can go as
low as pH 6.5 (Fig. 7B). This is enough to decrease the activity of
LL-37 and protect the parasite from direct killing. In contrast, this
pH adjustment was not seen in ST4-WR1 cultures and therefore
may be a reason why this isolate is more susceptible to LL-37
attack.
Blastocystis cells feature an outer surface coat (45, 46) that has
been proposed to confer protection to the parasite (5). We have
observed that the characteristics of this surface can vary from one
isolate to another. Using a negative stain (India ink), we observed
that the thickness of the surface coat is greater inBlastocystis ST7-B
than in Blastocystis ST4-WR1 cells (Fig. 8A and B). Using trans-
mission electron microscopy, the former also showed a denser
structure than the latter (Fig. 8C to F). Recently, a study found
LL-37 sequestration by a membrane-associated protein in a viru-
lent bacterium (47). This protects the bacterium by neutralizing
the activity of LL-37. It is also possible that some elements in the
Blastocystis surface coat have the same function. LL-37 was seen to
bind to the surface of the cell in the two isolates tested (ST7-B and
ST4-WR1), but isolate ST7-B was less affected than ST4-WR1, as
observed from the proportion of PI-stained cells (Fig. 9). It is
possible that due to the thickness and density of the surface coat of
the ST7-B isolate, LL-37 molecules may become trapped andmay
not have access to the parasite’s cell membrane. This would then
protect the cell from lysis.
Blastocystis ST1, along with ST3, is the most frequently de-
tected ST in parasitological surveys in the world (8). ST4 is com-
monly detected in Europe. These particular STs are highly sensi-
tive to LL-37 (Table 1 and Fig. 3 and 5). This could be one of the
reasons why most Blastocystis infections are asymptomatic and
self-limiting, as reported previously (5, 13). On the other hand,
ST7-B is relatively resistant to LL-37 and is also rare in terms of
being detected in human populations. This ST is also resistant to a
number of drugs, includingmetronidazole (13, 48), and is capable
of downregulating the expression of nitric oxide synthase (14),
which is an essential element in the innate immune response. Iso-
lates of ST7 have also been found to cause epithelial barrier dis-
ruption and have more adhesive properties in cell cultures (49),
thereby making this ST potentially more pathogenic than the rest
of the STs. Increases in prevalence rates of Blastocystis ST7 isolates
therefore would pose greater risks to the population.
In conclusion, this study explored the interactions between
Blastocystis and the antimicrobial peptide LL-37 (Fig. 10). This is
the first study to determine the effects of an important element in
FIG 10 Interactions between Blastocystis subtypes and LL-37. Blastocystis STs
induce epithelial cells to secrete LL-37. ST1 and ST4 are susceptible to LL-37
attack, while ST7 is relatively resistant. An isolate of ST7 (B isolate) is found to
secrete proteinases that degrade LL-37. It also decreases the pH, which de-
creases LL-37 activity. It also has a thicker surface coat that could possibly
protect the parasite against LL-37 binding. (The LL-37 structure was obtained
from RCSB Protein Data Bank [PDB] accession number 2K6O [50].)
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innate immunity toBlastocystis, a common eukaryote found in the
human colon. Our ex vivo and in vitro culture experiments indi-
cate that LL-37 is a significant molecule secreted by the host dur-
ing Blastocystis infections. We have also shown for the first time
that Blastocystis isolates are susceptible to the effects of LL-37. The
ST7-B isolate is able to alleviate the detrimental effects of this AMP
by various modes: first by the secretion of proteases that degrade
LL-37 and second by making its environment acidic, which is
enough to attenuate LL-37 activity. We also speculate on the pro-
tective function of the parasite’s surface coat against AMPs. This
study further differentiates the subtypes of Blastocystis, particu-
larly regarding host immune responses and the parasite’s ability to
evade these responses.
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Seeing the Whole Elephant: Imaging Flow
Cytometry Reveals Extensive Morphological
Diversity within Blastocystis Isolates
John Anthony Yason, Kevin ShyongWei Tan*




Blastocystis is a common protist isolated in humans and many animals. The parasite is a
species complex composed of 19 subtypes, 9 of which have been found in humans. There
are biological and molecular differences between Blastocystis subtypes although micros-
copy alone is unable to distinguish between these subtypes. Blastocystis isolates also dis-
play various morphological forms. Several of these forms, however, have not been properly
evaluated on whether or not these play significant functions in the organism's biology. In
this study, we used imaging flow cytometry to analyze morphological features of Blastocys-
tis isolates representing 3 subtypes (ST1, ST4 and ST7). We also employed fluorescence
dyes to discover new cellular features. The profiles from each of the subtypes exhibit con-
siderable differences with the others in terms of shape, size and granularity. We confirmed
that the classical vacuolar form comprises the majority in all three subtypes. We have also
evaluated other morphotypes on whether these represent distinct life stages in the parasite.
Irregularly-shaped cells were identified but all of them were found to be dying cells in one
isolate. Granular forms were present as a continuum in both viable and non-viable popula-
tions, with non-viable forms displaying higher granularity. By analyzing the images, rare
morphotypes such as multinucleated cells could be easily observed and quantified. These
cells had low granularity and lower DNA content. Small structures containing nucleic acid
were also identified. We discuss the possible biological implications of these unusual forms.
Introduction
Blastocystis spp. are protistan parasites found in humans and many types of animals. It is the
most commonly isolated eukaryote in humans [1,2]. Blastocystis is a species complex compris-
ing 19 subtypes (STs). ST1-9 have been found in humans and, with the exception of ST9, in
other animal hosts as well. Blastocystis ST1 and ST3 are most frequently isolated, but there is
geographical diversity in global distribution. For example, ST4 is common in Europe but not in
the rest of the world [3]. ST2 and ST6 had a higher occurrence than ST3 in a study in Colombia
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[4] and ST4 has not been detected at all. This was also the case in a study in Argentina [5]. ST9
had the lowest occurrence and was only found in Denmark and Japan [3]. Subtypes of Blasto-
cystis can be determined by genetic analyses, but STs also exhibit differences in size, morphol-
ogy, growth in culture, host range, drug resistance, host immune response, adhesion to host
cells and protease activities [6–10]. Studies have also indicated that ST identity may determine
symptomatology and pathogenic potential [5,11]. While its pathogenicity is still yet to be eluci-
dated, Blastocystis has been associated with gastrointestinal diseases [11]. It has also been
implicated in waterborne disease outbreaks [12,13]. Due to its ubiquity and numerous animal
hosts, it has the potential to be a threat in public health.
The conventional method for detection of Blastocystis is by microscopic observation in clini-
cal (mainly fecal specimens) and environmental samples. This method, however, is not ade-
quate to differentiate Blastocystis STs [6,14,15]. Under the microscope, Blastocystis appear
round with a prominent central vacuole. The cytoplasm is usually located at the edges where
the nucleus (or several nuclei) and other organelles can be found. Granular forms can also be
observed and some multi-vacuolar forms have been reported [6,16]. Irregularly-shaped cells
are also seen and these have been labelled as amoeboid forms in some studies [6,16,17].
There have been controversies on the life cycle of Blastocystis [18–21]. This is partly due to
the unknown status of several morphological forms observed both in culture and clinical sam-
ples. For example, multivacuolar forms have been thought as Blastocystis undergoing multiple
fission or schizogony similar to what happens in other protistan parasites [18]. There are also
suggestions that amoeboid forms may undergo plasmotomy [22]. Whether or not granular
forms have specific biological functions is still yet to be discovered [16]. There was also a report
on granular amoeboid forms expelling small granules in xenic cultures [16]. The authors how-
ever did not investigate further if these granules represent reproductive stages. Currently, only
binary fission has been accepted as the type of reproduction in Blastocystis since only this
mode has been observed. Other investigators also suggest that other forms may be artefacts
and do not represent reproductive stages [1,6,23]. There is, however, an interest on looking for
alternative modes of reproduction. For some, binary fission alone could not explain the high
number of cells in cultures and in fecal specimens [18]. Just like the parable of the blind men
and the elephant, various groups have reported on distinct forms without taking into consider-
ation the morphological complexity of the parasite. This often leads to biases and confusion in
the Blastocystis field. There is therefore a need to evaluate morphological forms exhibited by
Blastocystis in terms of their biological importance.
In this study, we used an imaging flow cytometer to survey the morphological characteris-
tics of 3 Blastocystis subtypes (ST1, ST4 and ST7). The Amnis ImageStream Mark II is capable
of acquiring thousands of images in a sample. These images can then be analyzed based on spe-
cific characteristics such as size, aspect ratio, fluorescence staining intensity, etc. We applied
this technique to characterize morphological features such as shape, size, granularity and loca-
tion of nuclei that can differentiate one subtype from the others. We also used fluorescence
dyes to visualize cellular structures such as vacuoles and nuclei. We then calculated for the pro-
portions of cells showing these features. This study is the first to provide a comprehensive and
unbiased overview of the various morphological forms of Blastocystis in culture and sheds new
light on the roles of certain forms of the parasite.
Methods
Parasite Axenic Cultivation
Blastocystis NUH9, WR1 and B isolates were maintained in 9ml Hyclone Iscove's Modified
Dulbecco Medium (IMDM) (GE Healthcare Life Sciences, Logan, UT) supplemented with 10%
Imaging Cytometry of Blastocystis
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horse serum (Life Technologies, Grand Island, NY). These isolates were previously axenized
[24–26]. NUH9 was isolated during a health screening from an asymptomatic patient [26];
WR1 fromWistar rat [24]; and B from a patient complaining of diarrhea [25,27]. Blastocystis
complete medium were pre-reduced for at least 12 hrs before use. Culture tubes were kept in in
5-L anaerobic jars with anaerogen gas pack (Oxoid, Basingtoke, UK) at 37°C.
Ethics Statement
Blastocystis isolate B was obtained from an existing collection at the Department of Microbiol-
ogy of the National University of Singapore (NUS). Human isolates were obtained from
patients at the Singapore General Hospital in the early 1990s, before Institutional Review
Board was established in NUS. NUH9 was isolated in 2007 from stool samples submitted for
routine heath screening and approval from the National Healthcare Group Institutional
Review Board was obtained before project commencement. All samples were anonymized.
Subtyping of Blastocystis Isolates
The isolates were previously genotyped using primers based on the organism's small sub-unit
ribosomal RNA (SSU rRNA) gene [26,28]. We also confirmed the isolates' subtypes using PCR
protocol based on DNA from the parasite's mitochondria-like organelle (MLO) [29]. Total
DNA were extracted from 1 x 106 cells using Qiagen DNA stool kit (Qiagen, Hilden, Germany)
following the manufacturer's instructions. PCR was perfomed using Q5 High-Fidelity 2X Mas-
ter Mix (New England BioLabs, Ipswich, MA) with 500 ng of DNA sample. All PCR runs were
completed using BioRad iQ5 thermocyler (Hercules, CA). PCR products were sequenced and
compared to National Center for Biotechnology Information (NCBI) (USA) nucleotide
sequence database to confirm subtype identities.
Fluorescence Staining and Imaging Flow Cytometry
In order to analyze cultures at the same stage of growth, 2-day old cultures of Blastocystis iso-
lates WR1 and B and 7-day old culture of isolate NUH9 were harvested. The cells were washed
twice by centrifugation at 1,000 x g using warm PBS. 2 x 107 cells in 200 μL PBS were collected
into 1.5 μL microtubes. The cell suspensions were then stained with 1 μg/mL propidium iodide
(PI) (BioVision, Mountain View, CA), 5 μM carboxyfluorescein succinimidyl ester (CFSE)
(Life Technologies, Eugene, OR) and 1 μg/mL Hoechst 33342 (Life Technologies, Eugene, OR)
for 15 mins. PI stain was used to select for viable and non-viable cells. Cells will only take up PI
when there is membrane disruption. CFSE is used in proliferation studies and is found to stain
vacuolar compartments of Blastocystis [8]. Hoechst stains the DNA and is useful for cell-cycle
analyses. Actively dividing cells will have higher emission while dying cells undergoing DNA
fragmentation will have lower fluorescence readings. The cells were then washed to remove
excess stains and fixed in 2% formaldehyde. Single stained cells were also prepared and used to
create a compensation matrix. Blastocystis cell suspension heated to 80°C for 15 mins was used
as positive control for PI-staining. We used Amnis ImageStream MarkII (Merck Millipore,
Seattle, WA) with 4-laser attachment (375, 488, 561 and 642) to acquire Blastocystis cell images.
2,000 events were obtained with low flow speed at 60x magnification. Images at extended
depth of field (EDF) setting were also acquired. EDF involves deconvolution to obtain highly
focused images. Gating strategy involved selecting for focused cells using RMS gradient values,
then for single cells using brightfield aspect ratio (Fig 1). Viable Blastocystis cells were identified
as those without PI-staining. Cell shapes were characterized using aspect ratios from brightfield
and CFSE staining. Acquisition was done using 3 different batches of cultures. Analysis of
images was performed using IDEAS software version 6.1.
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Statistical Analyses
The proportion of populations based on shape and granularity were analysed for significant
differences using Student’s two-tailed T-test. Hoechst-staining differences between groups
based on circularity were analysed for significance using ANOVA. Statistical analyses were
done using GraphPad Prism 5.0
Results and Discussion
Blastocystis cultures of NUH9, WR1 and B isolates were harvested at the log phase of their cor-
responding growth curves. NUH9 has the slowest growth rate and cultures from this isolate
were harvested after 7 days. Two-day old WR1 and B cultures were collected and used in the
experiment. Subtyping of the isolates using MLO-based primers confirmed the identities of the
isolates used: NUH9 is ST1, WR1 is ST4 and B is ST7. This step also made certain that each cul-
ture contain only one isolate/ST and was not contaminated by others.
Using imaging flow cytometry, both round and irregular shapes were found in all Blastocys-
tis isolates (Figs 2A and 3). The proportion of these shapes however differs from one subtype to
another. Viable Blastocystis ST1-NUH9 is exclusively round, but only 76% round (the rest are
irregular) in non-viable cells. Viable Blastocystis ST4-WR1 and ST7-B isolates are 83% and
Fig 1. Initial gating strategy to analyzeBlastocystis cells. Cells were gated for focused cells using brightfield channel, then selection of single cells using
aspect ratio and area units, and finally to classify viable and non-viable cells using PI-staining characteristics. The above graphs shows the analysis for
Blastocystis ST1-NUH9 isolate (A). Subsequent analyses made use of features arising from Hoechst and CFSE staining characteristics as well as features
from brightfield and side-scatter channels (B).
doi:10.1371/journal.pone.0143974.g001
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92% round-shaped, respectively. These proportions are slightly lower (82% for ST4-WR1 and
88% for ST7-B) in non-viable cells (Fig 2B).
Several studies have attached significance to amoeboid forms in terms of reproduction and
pathogenicity and these appear as irregularly-shaped cells [13,20]. These reports however did
not identify the subtype of Blastocystis they have observed. Past studies also did not take into
account the viability of the cells being observed. In this study, we were able to analyze morpho-
logical features of Blastocystis while determining their viability using PI-staining. We found
that irregularly-shaped cells in ST1 are non-viable and therefore may not have any biological
significance in this particular Blastocystis subtype. ST4 and ST7 isolates, on the other hand,
have viable irregularly-shaped cells. This irregularity are due either to the cells' elongated shape
or due to amoeboid features such as pseudopod-like structures (Fig 3). In our analyses, these
amoeboid forms are rare among viable populations as most irregularly-shaped cells (especially
in ST4) are elongated (Fig 3). In ST1 and ST4, these forms are more numerous but all are non-
viable. Analysis of cells from viable ST7 isolates showed only one cell (out of ~1000 cells) that
could be characterized as amoeboid (Fig 3). Experiments using different ages of cultures may
be done in the future to determine the consistency of these rare cells in the population. Like-
wise, xenic cultures can also be investigated as suggested [30] noting that amoeboid forms may
be more numerous in this type of culture condition.
Analysis of single Hoechst-staining was also done to further correlate Blastocystis shape and
reproductive status. Hoechst-staining is used for cell-cycle analysis. Actively dividing cells reg-
ister higher fluorescence compared to inert cells. In all the isolates studied, round-shaped cells
had higher average Hoechst-staining (Fig 4). This finding links well with the observation using
PI-staining that most irregularly-shaped may not have biological or reproductive roles at all.
Aside from the round vacuolar forms, round granular forms are also commonly observed in
clinical samples and in cultures [6,16]. Vdovenko [23] observed that these forms can naturally
arise from vacuolar forms possibly by environmental exposure or fixation artefact. A more
recent study has also mentioned this phenomenon [16]. In this study, we used the side-scatter
channel to measure granularity of the cells. The average intensity coming from the channel in
all STs in non-viable cells are higher compared to viable cells. Cells that are more granular can
be found mostly among non-viable cells (Fig 5A). Non-viable cells have wider range in terms
of granularity in contrast to viable cells where these tend to have lower side-scatter channel
intensity. These findings are consistent among the 3 STs studied (Fig 5B). Nevertheless, cells
that are more granular can also be found among viable cells. Our data suggests that there exists
two populations of granular cells: true granular cells and those that are degenerating (Fig 5C)
as reported previously [1,23]. We also add that granularity of these dying cells may be due
more to environmental exposure rather than caused by fixation since we have observed the
same proportion of granular forms in both fixed and unfixed samples (data not shown). We
also used the Hoechst staining intensity of viable granular cells to find their biological signifi-
cance. We have observe that these cells have higher DNA content compared to granular ones
(Fig 6) These cells may therefore be in a more active reproductive state compared to less granu-
lar ones. We also analysed the granularity of multinucleated cells.
Fig 2. Gating for round and irregular shapes ofBlastocystis. The shapes of Blastocystis were selected based on aspect ratios from the brightfield
channel (M03) and CFSE staining (M02). Viable and non-viable cells were plotted separately. The above graphs shows the gating for Blastocystis
ST1-NUH9 isolate (A). The average proportion of round and irregular shapes fond in cultures of Blastocystis ST1-NUH9, ST4-WR1 and ST7-B were then
plotted in a graph (B). These are based on three separate batches of cultures and independent runs in ImageStream. Error bars signify standard error values.
p-values comparing the proportion of round cells between viable and non-viable populations are 0.06, 0.47 and 0.31 for ST1-NUH9, ST4-WR1 and ST7-B
isolates, respectively.
doi:10.1371/journal.pone.0143974.g002
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Fig 3. Blastocystis STs display various shapes from both viable and non-viable populations. Image gallery of Blastocystis cells showing round and
irregular shapes from viable and non-viable populations. Each cell shown in the brightfield (BF) view has corresponding images which display CFSE and PI
staining. The latter was used to determine viability. Irregular-shaped cells show elongated cells and amoeboid forms. Amoeboid forms with prominent
pseudopodia and filamentous attachments are restricted to non-viable forms ST1-NUH9 and ST4-WR1. There are rare (0.1%) cells in viable ST7-B
population that show an amoeboid-like morphology.
doi:10.1371/journal.pone.0143974.g003
Imaging Cytometry of Blastocystis
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The diameter of Blastocystis vacuolar forms have been estimated to be between 2 and
200 μm [6]. A study MacPherson and MacQueen [31] indicated that the diameter of 80.8% of
the Blastocystis they observed fell between 5 and 15 μm. This paper, however, was published
before the genotyping era and so the particular ST of the isolate is unknown. In this study, we
determined the size ranges of viable cells in each of the three subtypes. ST1-NUH9 and ST7-B
isolates are bigger compared to ST4-WR1 isolates (Table 1). Furthermore, more than half
(51.7%) of ST1-NUH9 cells have diameter of greater than or equal to 5 μmwhile only 37.3% of
ST7-B cells have this size. ST4-WR1 cells are generally small with diameter of less than 5 μm in
98.3% of the population. Mirza et al. have previously reported differences in sizes between ST4
and ST7 isolates using flow cytometry [32]. In that study, the diameter of majority of Blastocys-
tis cells after 48 hours of culture were 6 to 10 μm and 3 to 6 μm for ST7 and ST4 isolates,
respectively. The calculations made for ST4 in this study mirrors that of the previous report.
However, the measurement in this study for ST7 is smaller. The previous study has determined
the sizes indirectly using known-sized beads and set them as standards for the forward scatter
channel values in flow cytometry. This study however makes use of actual images of the cells
and converting the pixel measurements to micrometers. We were also able to exclude doublets
Fig 4. RoundBlastocystis have higher DNA content. Blastocystis cells were plotted according to circularity using the software’s shape wizard. The
population of cells was then divided into three groups: low, mid and high circularity (A). A dot-plot was generated to analyze the relationship between
circularity and DNA content indicated by Hoechst staining of Blastocystis cells (B). The dot-plot shows that some highly circular cells have the highest DNA
content while the least circular cells have the lowest DNA content. Bar graphs show the average Hoechst-staining of the three groups of Blastocystis cells
based on circularity (C). Differences between groups based on circularity in each ST were found to be significant (p < 0.05) using ANOVA.
doi:10.1371/journal.pone.0143974.g004
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Fig 5. Analysis of Blastocystis based on granularity. Blastocystis populations were plotted according to
mean pixel intensities of both side scatter channel and PI staining to determine the cells' granularity and
viability, respectively (A). Cells with higher PI staining have more granularity compared to cells with lower PI
staining. This observation is common to all subtypes used in this study as shown in a graph (B); *, p < 0.05.
Sample images showing cells with high granularity among viable and non-viable populations (C). These cells
may represent true granular cells and degenerating cells, respectively.
doi:10.1371/journal.pone.0143974.g005
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in measurement. There might be bigger-sized cells depending on the type and age of samples
as well the amount of initial inoculum. Our analyses highlight the importance of taking into
account the subtype used in any morphological studies. Our data suggest that the size range of
Blastocystis is not as wide as between 2 and 200 μm, but narrower when ST identity is estab-
lished. We also specifically measured viable cells only as the non-viable cells may feature
degenerating cells and assume irregular shapes (Table 1).
We used Hoechst staining and the EDF setting of the imaging flow cytometer to analyze
nuclear arrangement of viable Blastocystis cells. More than 80% of the population from the
three subtypes studied featured 1–2 nuclei (Fig 7) located at the edge of the cells. ST4-WR1 iso-
lates all feature one or two nuclei (and not more). This reflects the previous observation [31]
whereby 98.4% of the cells have a similar arrangement. This study therefore supports the classi-
cal representation of Blastocystis. More infrequently, in the other STs (1–2% in ST1 and 2–8%
in ST7), other nuclear features were observed. These cells either show more than 2 nuclei or
that the nucleic acid stain covers a large area of the cell (Fig 8). The latter show an apparent
nucleic acid condensation which may represent cells about to undergo binary fission. Surpris-
ingly, we have observed multinucleation only in round cells in these two subtypes. We did not
find evidence to support alternative modes of reproduction such as plasmotomy and budding
in Blastocystis as suggested by others [16,18,22] since we did not observe multinucleation in
irregularly-shaped viable cells. Some of the multinucleated cells show the nuclei located in the
center of the cell with the size of the central vacuole diminished (as indicated by lower intensity
of CFSE staining) (Fig 8A). If this is a reproductive stage, it may be an evidence of a multiple
fission event in Blastocystis as suggested [33]. These, however, showed lower granularity
Fig 6. ViableBlastocystis cells with high granularity have higher DNA content.Dot-plot shows the populations of Blastocystis cells plotted according to
circularity and Hoechst staining.
doi:10.1371/journal.pone.0143974.g006
Table 1. Viable Blastocystis size profiles indicated by cell diameter range and average diameter.
Subtype-Isolate Diameter Range (μm) Average Diameter (μm) Cells with diameter  5 μm (%)
ST1-NUH9 2.7–8.7 5.0 ± 0.8 51.7 ± 6.1
ST4-WR1 2.2–6.2 3.6 ± 0.6 1.7 ± 0.4
ST7-B 3.2–7.5 4.9 ± 0.7 37.3 ± 4.5
doi:10.1371/journal.pone.0143974.t001
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(Fig 9). Cells with single or two nuclei also showed higher DNA content. This is consistent
with the data above (Fig 6) and these suggests that multinucleated cells may not be in active
reproductive stage as compared to the other cells. We have also observed small structures con-
taining nucleic acid (Fig 8B). These structures are rare (2–4% of viable cells). They also do not
appear to have vacuoles as indicated by low CFSE staining but consist mainly of nucleic acid
material in its compartment. Our experiments did not determine whether these structures orig-
inate from bigger and multinucleated cells. It may also be possible that these represent starving
cells or a state where Blastocystis sheds off its vacuole.
Conclusions
In this study, we analyzed three STs of Blastocystis based on shape, size, granularity and
nuclear arrangement using high content imaging flow cytometry. These features may be
used to compare one Blastocystis ST to another. We have also identified rare multi-nuclear
forms which are unlikely to represent an alternative mode of reproduction in the parasite. It
would be interesting to investigate other isolates coming from the same or other STs so that
Fig 7. Image gallery of Blastocystis showing classical morphological forms at varying sizes in the viable populations. Images were acquired using
EDF setting of the imaging flow cytometer. Each cell is represented by two images: Hoechst-CFSE-staining composite and brightfield image. The nuclei were
stained with Hoechst and the vacuole with CFSE. These round forms show a single nuclei located at the edge of the cell. These forms comprise more than
half of the population in all the subtypes studied.
doi:10.1371/journal.pone.0143974.g007
Fig 8. Image gallery of rareBlastocystismultinucleated cells. The nuclei is visualized by Hoechst staining. The nuclei number more than three and some
appear to be concentrated in the center and not along the edges (A). Some of these cells also appear to show nuclear condensation. (B) Image gallery
showing small structures which contains DNA.
doi:10.1371/journal.pone.0143974.g008
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inter- and intra-subtype variations in morphology can be determined. We used axenic cul-
tures of Blastocystis but it would also be attractive to investigate cells from xenic cultures or
from fecal samples. The methods outlined in this study can also be used to detect changes in
Blastocystis upon treatment of drugs or modification of culture conditions. Data from this
study provides an important and useful reference on the morphological profile of Blastocys-
tis STs.
Fig 9. MultinucleatedBlastocystis cells do not display higher granularity compared to uninucleated cells. The spot wizard of the IDEAS software was
used to group cells based on number of nuclei. This was done by counting the ‘spots’ stained with Hoechst. The images were then visually analysed to
determine the precise spot values that correspond to the number of nuclei (A). Dot-plots were generated for each ST to analyse granularity in multinucleated
cells. These plots show that cells with high granularity are found in the populations of uninucleated cells.
doi:10.1371/journal.pone.0143974.g009
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